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Discovery proteomics is advancing at a rapid rate, and quality control of the technique must 
adapt accordingly. In 2012, a console application, QuaMeter, was created to produce quality 
control metrics for data-dependent proteomics based on metrics first designed by the USA 
National Institute for Standards and Technology (NIST). In 2014, the tool gained an 
identification-independent mode, which can generate 44 quality metrics still applicable only to 
data-dependent acquisition. However, the development of new data-independent acquisition 
methods in recent years introduces the need for a data-independent acquisition version of 
QuaMeter. The QuaMeter metrics must also still be analysed in a statistical framework such as 
R/Python to gain full value of the multivariate nature of the metrics. Biologists who are 
inexperienced at programming/ using a console might therefore find the use of such software 
limiting and there is a desire for a tool with a user interface with which to analyse the metrics.  
Here, I have created a console software for the analysis of data-independent acquisition results. 
The tool provides a platform for in-depth analysis of data quality. The tool is the first of its sort to 
allow the user to divide the retention time into segments and return quality metrics for each 
segment separately. This allows the researcher to gain extra insight into the chromatography 
steps, and as I illustrate here, the tool illuminates problems that would not have been visible if 
only one metric was provided for the entire file. In addition, the m/z axis is split into the data’s 
underlying isolation window structure and metrics calculated for each window separately to 
equip a researcher with additional information for method development. A set of metrics is also 
added which produce one value for the entire file for easy outlier detection among files.  
This project also involves the creation of a desktop application with user interface for running 
either of the two console applications. This tool can also perform some of the key downstream 
analysis regularly performed in quality control. Outlier detection is enabled via PCA, 
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classification of longitudinal data as good or bad quality is performed with random forest 
analysis and individual metrics can also be visualized against their distributions. In addition, 
many quality control principles are explained and demonstrated in the context of the quality 
control metrics, such as experimental design, identifying sources of variability in an experiment 
and conventional quality control techniques such as outlier detection and classification of data 
quality are demonstrated. 
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Opsomming 
Proteïen-massaspektrometrie maak die afgelope dekade baie vinnig vordering en die 
gehaltebeheer van die tegniek moet derhalwe dienooreenkomstig aangepas word. In 2012 is ’n 
konsole-toepassing, QuaMeter, vir die voortbrenging van gehaltemetings vir data-afhanklike 
proteoomanalise geskep. Hierdie weergawe van die toepassing is op ’n toepassing deur die 
Amerikaanse National Institute for Standards and Technology (NIST) gebaseer. In 2014 is ’n 
identifikasie-onafhanklike weergawe van die sagteware bygevoeg, wat 44 gehaltemetings 
rapporteer, maar steeds net vir data-afhanklike verkrygingstegnieke. Meer onlangs is daar egter 
nuwe data-onafhanklike verkrygingsmetodes ontwerp wat redelike steun in die gemeenskap 
geniet. Daar het dus ’n behoefte aan ’n data-onafhanklike weergawe van QuaMeter ontstaan.  
Die resultate van QuaMeter moet egter steeds stroomaf deur ’n statistiese raamwerk soos 
R/Python geanaliseer word om die meerveranderlike aard van QuaMeter ten volle te benut. 
Bioloë wat onervare in programmering of die gebruik van ’n konsole is, mag dit dalk as ’n 
onoorkomelike struikelblok beskou. Ek het derhalwe ’n konsole-sagteware, SwaMe, vir die 
analise van data-onafhanklike verkrygingsresultate gebou. SwaMe verskaf ’n platform vir ’n 
meer diepgaande analise van die datagehalte. Dié hulpmiddel is die eerste in sy soort wat die 
gebruiker toelaat om die retensietyd in segmente te verdeel en gehaltemetings vir elke segment 
afsonderlik te bereken. Sodoende kan die navorser insig verkry in die chromatografie, en soos 
ek hier aantoon, word instrumentele probleme uitgewys wat nie sigbaar sou gewees het indien 
daar slegs een waarde per monster gerapporteer was nie. Die m/z-as word in die data se 
onderliggende isolasievensterstruktuur onderverdeel en gemiddelde metings word vir elke 
venster afsonderlik verskaf, wat metode-ontwikkeling verder vergemaklik. ’n Stel metings wat 




Die projek sluit ook die ontwerp in van ’n grafiesekoppelvlak-toepassing, Assurance, wat ’n 
platform bied om die twee konsole-toepassings aan te wend. Dié werktuig kan ook help met die 
uitvoering van sekere van die belangrikste stroomaf statistiese analise. Dit word gereeld in 
gehaltebeheer uitgevoer en sluit in uitskieter-identifisering van hoofkomponentanalise en die 
klassifisering van longitudinale data as goed of sleg deur masjienleer; die visualisering van 
individuele metings met die dataverspreiding kan ook plaasvind. Talle gehaltebeheerbeginsels, 
soos eksperimentele ontwerp en die identifisering van bronne van veranderlikheid, word ook 
verduidelik en in die konteks van die gehaltemetings gedemonstreer. Daarbenewens word 
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Computational and technical advances have paved the way for the highly sensitive, efficient 
discovery proteomics analyses we have available today. Liquid chromatography mass 
spectrometry (LC-MS/MS) is currently the preferred method for protein identification and 
quantification for many researchers. Advances such as hybrid mass analysers,1,2 orbitrap mass 
analyzers,3 optimisation of time of flight (TOF) detectors for increased spectral acquisition rates, 
and multi-dimensional separation techniques4 have contributed to the sensitivity and resolution 
power of the instrument. The specificity of mass analyzers allows accurate selection of isolation 
windows for targeted analyses. In addition, the increased dynamic range provided by 
technologies such as TOF increase the applicability of the technique to discovery proteomics on 
complex samples or entire proteomes.  
Different acquisition methods broaden the scope of discovery proteomics, such as ‘shotgun’ 
proteomics, a data-dependent acquisition (DDA) method for protein identification (the name was 
first applied by the Yates lab in 1998).5 The technique starts with a scan of all peptide ions 
within the dynamic range, MS1. In the next step, peptides are selected from the MS1 scan, for 
example the top 20 most abundant peptides. One by one, these precursor peptides are selected 
for fragmentation, and the product ions are detected in an MS2 scan. The selected peptide m/z 
values are also added to a dynamic exclusion list for a specified time period (for example 30s). 
As the m/z values of both precursors and products are known, identification of the peptides in 




drawbacks of the method are mostly linked to the stochasticity of the selection process. 
Between runs of the same sample, the peptides selected may differ quite substantially and of 
the peptides identified in MS1, as low as 16% are targeted for MS2.7  
More recently, a data-independent acquisition (DIA) method, also known as Sequential Window 
of All Theoretical mass spectra (SWATH),8 was developed where broader, overlapping windows 
(e.g. 25m/z with 1 m/z overlap) covering the dynamic range are selected in m/z order for 
fragmentation. The fragments are identified by matching to either a public spectral library or a 
self-created library, for example one created from DDA data on a similar instrument. Here, the 
MS1 scan is optional and the lack of a precursor to relate to the product ions results in very 
complicated bioinformatic analysis to identify peptides. In addition, In contrast to the stochastic 
sampling process of DDA, identification using DIA should theoretically be more repeatable and 
reproducible. This technique has been made possible by faster scanning technology. Initially the 
efficiency of the technique also depended on the spectral libraries available and the additional 
cost of acquiring DDA runs to create a library was a drawback of this technique. However tools 
now exist for spectral analysis without a library, such as the software tool, DIA-Umpire.9 For 
researchers who prefer creating a library from DDA experiments, a recent paper explored 
including DDA and DIA in the same run. Negating a separate run for library creation, this would 
lessen the financial burden. They found their technique compared favourably with DIA-Umpire 
and was able to identify more protein-groups than library-free analysis.10 
 
As proteomics advances, so too must proteomic quality control. Each new step adding 
complexity and contributing variability should be identified.  Proper methods to monitor the 
relevant steps should be established, whether computationally or via bench practices. 
According to Whitney and colleagues,11 quality assurance (QA) refers to the steps taken before 
a protocol has begun, spanning the planning of the experiment, identification of the potential 




Quality control (QC) refers to the activities that monitor and correct for, if possible/necessary, 
the data collection and analysis.11 As part of quality assurance, it is extremely important that a 
mass spectrometry researcher be able to predict the possible sources of variability before 
performing an experiment as well as identify the main contributors toward poor instrument 
performance as well as data quality. Before the experiment, the knowledge of variability factors 
can be used in the study design as far as possible. During the experiment, quality control 
analysis may be able to monitor some of these parameters via bench techniques or QC metric 
producing software and correct for them where necessary. After the data analysis, these 
sources of variability should be taken into account when discussing results, and if a batch effect 
occurred, this should be very clearly conveyed in the discussion and the validity of the results 
discussed. 
1.2 Quality assurance  
An argument can be made that QA involves the design of the experiment, the identification of 
possible problem areas, whilst adhering to or at least taking into account guidelines and 
recommendations.  
1.2.1 Institutions, standards and guidelines for proteomic reproducibility and QC  
Increasing reproducibility remains an important goal in proteomics, so much so that in a 2002 
meeting of the Human Proteome organization (HUPO) the proteomics standards initiative 
(HUPO-PSI) was initialized.12 The initiative focuses on setting standards in terms of file formats, 
controlled vocabularies and more. There is also a working group for quality control specifically 
which is currently working on a standard file format in which quality control results can be 
output, mzQC. America boasts the National Institute of Standards and Technology (NIST- 
accessible at www.nist.gov), an organization that has produced not only countless articles on 




(also known as shotgun) data.13 In addition, the European Bioinformatics Community (EuBIC) 
have set up a project which aims to create guidelines for reproducible mass spectrometry 
experiments. These guidelines will be published to allow their incorporation into journals and 
data repositories alike. 
A researcher in search of mass spectrometry guidelines might find valuable chromatography 
metrics in the chromatography section of the United States Pharmacopeia (USP).  The USP 
also contains two mass spectrometry sections: one in the general chapters section14 as well as 
one for applications of mass spectrometry as chapter 1736 in the 39th issue. However, the USP 
treats each part (sample preparation, chromatography and mass spectrometry) separately, with 
the latter left to manufacturer's instructions.  
The United States Food and Drug Association (FDA) on the other hand has more specific 
guidelines.15 Some of the requirements include for example that at least one control and one 
fortified sample be run daily. In addition, blank samples should be run after standards/ fortified 
controls to ensure carry-over does not take place.  
It is also a defining characteristic of almost all accreditation facilities to require extensive date-
stamped paperwork to back up any quality decision. It is therefore imperative that whichever QC 
software is used, a report of some kind is generated that can be stored and presented in an 
audit.  
1.2.2 Experimental design  
There are two main experimental design methods to ensure that within a study, one group of 
data is not exposed to higher levels of variability than another.  
 
The first, detailed in 1927,16 is blocking. This approach involves identifying the sources of 
variability that cannot be corrected for or changed, for example an experiment where two 




is then confounded with other problem areas. In order to maintain a low impact on the results, 
blocking factors must be established. These include factors in the study that are not directly 
involved in the biological questions but that may cause between-sample variability. A good 
example might be the gender of patients in a drug trial. The blocking factor must then be spread 
equally among the different blocks. Unfortunately, it is not probable that a researcher will be 
able to think of every possible source of variability, and even if it were possible the sample size 
of most studies would complicate creating a block for every possible source.  
 
The second involves randomizing the sample order so as to correct for all sources of variability, 
not just the known sources. This method prevents bias and can distribute all variability evenly. 
However, this can also cause bias to a certain extent. In a case-control drug trial for example, 
pure randomization could, by definition, place all the cases together and all the controls 
together. An issue such as instrumental drift may then cause an effect that may appear to be of 
biological significance. 
 
The preferred approach is therefore randomized block design as reviewed by Oberg and 
Vitek.17 For the variables that cannot be blocked/have not been identified, a researcher is able 
to apply randomisation within each block. In this case instrumental drift of the LC-MS/MS 
instrument may prove a useful example where the samples run directly after calibration of the 
instrument may show more repeatable results. Consequently, the order of the samples should 
be randomised to protect against a bias. Randomisation should occur within the assigned 
blocks. There are various algorithms by which to effect randomisation,18–20 else a random 
number table could be used similar to one provided by the National Institute for Standards and 
Technology (NIST) handbook appendix B.21 This type of experimental design is more easily 
achieved in some experiments than others. Due to differences between samples originating 




if the groups are randomised. However, it is imperative that randomisation be applied as widely 
as possible. 
1.2.3 Sources of variability in a discovery proteomics experiment 
In order to effectively implement a randomized blocking strategy, it is important to identify the 
potential sources of variability present in the experiment. Here, these nuisance factors have 
been classified into two main steps - sample preparation and data acquisition. 
1.2.3.1 Sample preparation 
Sample collection 
Although QC should be an integral part of study design, implementation of QC steps should 
begin with sample collection and if the experiment calls for it, sample creation, growth etc. 
Whether the collection includes harvesting cells, drawing blood or collecting tissue, this process 
should be done with the source of variability in mind. Hassis and colleagues in 2015 found the 
majority of plasma-related sample handling errors occur due to recontamination with whole 
blood during centrifugation,22 whereas Geyer and colleagues, 2019, found platelets, 
erythrocytes and coagulation to be the most common quality concerns for this sample type.23 
Environmental variables such as temperature, humidity, buffer/media composition should be 
closely monitored. Any researcher who has run an autoclave frequently enough is aware that 
even the best attempts to create a reproducible run can result in significant colour or volume 
differences in growth media between autoclave runs, which in turn can affect biological 
conclusions.  Similarly, batches of swabs, petri dishes and other consumables presumed to be 
sterile can be contaminated before receipt.  Batches of sterile consumables, reagents, 




In addition, the complexity of the proteome is such that slight sample handling errors can cause 
statistically significant differences in the measured proteome.22 Geyer and colleagues, 2019,  
published recommendations for plasma quality including panels of proteins that can serve as 
contamination indices, along with a tool with user-interface with which MaxQuant24 results could 
be added and analyzed for contaminants. 23 The authors, after doing a meta-analysis found 
54% of biomarker panels they analyzed to include what they consider to be contaminants/ 
preparation artifacts. 
It is important to develop a standard method or in the case of more than one sample collector, a 
standard operating procedure for the sample collection. Different sample collectors and more 
broadly sample sites should be included in the blocking structure if possible. 
Sample composition 
Samples containing protease inhibitors or anticoagulants could interfere with digestion. 
Similarly, samples containing proteases could affect results.25,26 Guiding bodies such as HUPO 
have acknowledged sample type inequality and have recommended the use of plasma over 
serum samples due to increased reproducibility.27 In addition, the location of proteins in a 
sample can have an effect. For example, it can be difficult to solubilize membrane-bound 
proteins.28 
Sample storage 
Although sample type again causes variation in this factor,26 sample storage eventually affects 
the viability of all sample types. In addition, fixing samples with formalin and embedding in 
paraffin (FFPE) can result in two main issues for proteomics. Firstly, a variety of modifications 





Protein extraction method is highly dependent on various aspects of the study. The sample type 
may require the removal of artifacts such as paraffin or disintegration of a frozen sample.31–35  
The characteristics of proteins in question may require a different temperature or pH for 
extraction.36 The location of the desired proteins within the cell may also play a role. Membrane 
proteins are a good example as their extraction requires alkaline or acidic buffers, detergents, 
salts or organic solvents.37–40 The biological question of the study may therefore require severe 
changes to be made to the extraction protocol. A study that is looking for all possible proteins 
present in the entire cell may even require multiple extraction phases. 
Protein solubilization 
In this step again the biological question plays a role. For example, solubilization under native 
conditions will have to be performed for protein interaction studies. For such cases mild 
detergents such as Tween and CHAPS can be applied. On the other hand use of the anionic 
detergent sodium dodecyl sulfate (SDS) will abolish all biological activity and interactions but 
this is an efficient approach for unbiased solubilization of the total proteome. Chaotropes such 
as urea are other popular solubilization alternatives. Urea, however, has been shown to result in 
carbamylation of the peptide N-termini and Lys/Arg side chains, interfering with digestion. In 
addition, it also affects ionisation and leads to unexpected retention time (RT).41 This is further 
complicated by the age and environmental conditions such as temperature and pH playing a 
role in the efficiency of the denaturation as well as the degree of methylation.42,43 
Reduction and alkylation  
Disulfide bonds within the protein structure need to be broken in order to completely unfold the 
protein prior to proteolysis. In order to prevent the thiol groups from forming another disulfide 




result in N- as well as S-carbamidomethylation or N- or O-alkylation, which can interfere with 
identification by changing the expected m/z value of the peptide/fragment.44 
Digestion 
The choice of enzymes for digestion purposes is crucial as the enzymes differ not only in 
cleavage sites, but also in reproducibility, specificity and sensitivity. Trypsin is the most 
commonly used enzyme for this purpose due to its high specificity and its production of peptides 
with a basic C-terminus that are ideally suited to ionisation and fragmentation.45 In addition, 
there is a certain safety in using the most popular enzyme, such as reduced cost and 
widespread availability as well as having increased support amongst bioinformatics toolsets. 
Between batches, trypsin has been reported to show relative reproducibility, with the origin 
(bovine or porcine) showing significant effect on the reproducibility of the study.46 In addition, 
slight changes in pH during digestion, incubation temperature,47,48  pH,48 incubation time with 
the sample,49 as well as enzyme-to-substrate ratio can result in differences in efficiency.50 
However, even amongst replicates using an enzyme of the same origin, some variation can be 
seen.51 This is of particular concern in a technique such as LC-MS/MS where the volumes in 
question leave very little margin for error. 
Pipetting variation 
The small volume also increases the need for an extremely reproducible pipetting procedure. 
Factors to consider include the handler’s technique and the tip shape and material. Even the 
time spent in the hand of the handler might warm the internal temperature of the pipette, 
resulting in a slight variation in suction power.52  
Depletion and enrichment 
The presence of highly abundant ions in a sample can mask less abundant ions and prevent 




proteins/peptides is often performed to solve this problem. There are many different methods for 
performing depletion, and commercial kits and columns available for this purpose vary in 
reproducibility.53 However, studies have also shown that depletion can reduce variance in peak 
ratio, reducing variability in the mass spectrometry process itself54 or simply reducing CV’s of 
the quantification results.55 Other studies warn about the importance of carry-over when 
multiple-use depletion devices are used and recommend, where possible, single-use 
devices.56,57 The pH during the enrichment process is of particular importance to maintaining 
high levels of efficiency.58 The difficulty in using either depletion or enrichment is to do so 
reproducibly. Hakimi and colleagues stated that in their lab, enrichment has shown to be more 
repeatable than depletion, however, a larger sample volume is required.59   
Fractionation 
Another approach to reducing dynamic range and complexity is through the use of various  
fractionation techniques that result in the subdivision and thus simplification of the source 
sample, each time only processing a fraction of the peptides. Fractionation can occur at protein 
or peptide level  and some of the more common characteristics on which peptides/proteins are 
fractionated include size, hydrophobicity and mass. Both size-exclusion chromatography(SEC) 
and Sodium-dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) has been shown 
to result in the analysis of proteins that differ from their expected m/z values, possibly due to 
protein complexes rather than individual proteins being separated in cell lysates.60 Fractionation 
techniques may also result in sample losses.61 In addition, techniques vary in their 






All of the above-mentioned steps will require the addition of chemical reagents  and the 
interaction of these with each other as well as with the column and mass spectrometer must be 
very carefully considered. For example, SDS is known to inhibit digestion and will also result in  
ion suppression as would presence of other detergents and polymers such as polyethylene 
glycol (PEG).63,64 The effect of SDS on digestion is also inconsistent among proteins, adding to 
variability.65 Salts in the sample can interfere with the ionisation procedure, thereby affecting 
end results. Sample cleanup methods, which could be based on solid-phase extraction (SPE), 
precipitation or ultrafiltration are often multistep and thus differ in efficiency, further contributing 
variability to the experiment.66 
Labelling 
A researcher may choose to label samples in a comparison study at either protein or peptide 
level. Stable isotope labelling strategies can loosely be classified as belonging to either isotope 
coded affinity tags,67 isobaric tags,68 N-terminal tags, stable isotope labeling with amino acids in 
cell culture (SILAC),69 or terminal amine isotopic labelling of substrates (TAILS). Through these 
various labelling options, multiple samples can be included in the same run and their relative 
abundances compared, whereby issues of instrumental drift or other intra-run complications are 
applied to both samples/conditions. However, labelling itself introduces variability into the 
analysis. Labels have been known to bind to contaminants or simply be subject to incomplete 
binding.70 
1.2.3.2 Instrument based variability 
In a study by Piehowski and colleagues, the variability contributed by the instrument was less 




high level of variability contributed by the instrument is problematic, as much of the system is 
closed and checking the quality mid-analysis is often not an option. 
Chromatography 
During the chromatography stage, solvent composition can have disastrous effects on the 
retention time (RT), whilst ionic strength and consistency of mobile phase and composition of 
buffer, column particle size, length, flow rate and gradient can greatly affect resolution.71–76 The 
large influence of detergents and solvents on column efficiency further emphasizes the 
importance of reproducible and effective sample clean up. The column is also subject to 
degradation, which manifests as changes in the RT, peak shape or column efficiency/selectivity 
which may be mistaken for biologically significant results.77,78  
Ionization 
Sample complexity again plays a role in the realm of ionisation due to matrix interference. 
Inefficiency of desalting and protein extraction could create problems here, resulting in 
insufficient or selective ionization.79,80 This highlights the importance of proper sample cleanup. 
In addition, solvents and electrolytes can also suppress ionization and spray position in relation 
to the MS opening play a role.81  
Instrumental platform 
Several other instrument problems have been noted and may cause mass error such as power 
supply voltage changes, temperature/ humidity fluctuations, vacuum system problems.82 
Evaluating the instrument as a whole, the Thermo Fisher Orbitrap has been shown to have 






Cycle time refers to the time between the acquisition of the entire set of scans to the next start 
of the same sequence, for example the time from one MS1 scan to the next. A short cycle time 
and therefore fast acquisition is imperative for quantitative proteomics.8 During fragmentation of 
DDA and most DIA methods, only a small number of ions are selected for detection. Any other 
ions eluting during an MS2 scan will not be interrogated and are lost to the analysis. It is 
therefore very important that the time spent to collect a cycle be as short as possible. 
Isolation window structure 
Different patterns exist for DIA isolation window structure. The classic original pattern described 
by Gillet and colleagues in 20128 involves moving sequentially through the m/z range with 
windows of around 25m/z with an MS1 scan at the start of each cycle. The MacCoss laboratory 
has tried a few other methods. A notable example is the MSX method which involves the 
acquisition of five isolation windows per scan that are a mere 4 m/z in size randomly scattered 
over the dynamic range.84 In another example, the group sets an offset for the windows, where 
the cycle consists of two rounds of windows covering the dynamic range, where the second 
round is offset by 10m/z.85 In addition, instead of using windows of a fixed size, variable window 
sizes have also been suggested.86 The latter strategy involves software analyzing the peptide 
distribution of the sample, then allocating smaller windows to the more densely populated 
sections of the m/z axis. This strategy has been shown to result in a 10-13% increase in the 
number of identified proteins.86  
Under-sampling 
In DDA, undersampling is the under representation of proteins (usually of low-abundance) in the 
LC-MS/MS results. Precursor sampling for this acquisition technique is stochastic in nature and 




fragmentation, the exact intensity of peptides differ between runs and the chosen peptides 
therefore also differ. Wang and colleagues make the argument that proteome coverage is 
directly linked to reproducibility due to undersampling.63 One study showed as little as 30-65% 
overlap in identified peptides between two technical replicates.64     
 
Trap/detector saturation 
Saturation in mass spectrometry is the tendency of a detector or in the case of certain types of 
mass analysers to not be able to detect ions that exceed a certain abundance. The result is 
usually a forward-tailed peak and/or a peak with a flat top, flattening at the point of saturation.87 
Intensity is quite variable between runs and exact intensity is almost never compared between 
runs. By causing the ratio to differ in samples where saturation took place, reproducibility as well 
as biological conclusion could be greatly affected. 
1.3 Quality Control 
The identification of possible sources of variability is of course not enough. A proper quality by 
design approach also includes monitoring and corrections for quality anomalies where 
possible/necessary. 
1.3.1 Bench solutions 
In the context of a biomarker trial, Percy and colleagues21 recommend not performing peptide 
enrichment or protein depletion to minimize variability and thereby avoid both extra cost and 
unnecessary loss of proteins from the analysis. 
Regarding denaturation concerns, the age of the urea used is extremely important. The same is 
true of environmental conditions (temperature, pH) during both denaturation and digestion. 




Digestion variability can be monitored by commercially available digestion indicators, such as 
those from Thermo Scientific which consists of a non-mammalian recombinant protein.88 In 
addition, studies have shown that decreasing the enzyme to substrate ratio decreases the 
chance of autolysis of trypsin. At a larger substrate to enzyme ratio, studies have also shown 
that the enzyme becomes more efficient at digesting smaller substrates rather than proteins of 
interest, so maintaining the correct balance can therefore aid in reducing variability.89,90  
 
In order to overcome the crosslinks formed during formalin fixation, techniques exist that include 
combinations of high temperatures, sonication, high pressure and reagents such as sodium-
dodecyl sulphate (SDS) are often added to the buffer to keep proteins in solution.31,32,35 SDS is 
also used in solubilizing membrane proteins. However, SDS clusters can dominate the mass 
spectra, masking signals from any analytes of interest and must therefore be removed quite 
diligently.28 
Another commercial solution that has been created to address a variability problem includes 
attempting to overcome pipetting technique errors with robotics. Sample handling machines 
such as Thermo Fisher’s KingFisher™ Flex Magnetic Particle Processor, Leap Technologies 
CTC Analytics PAL® Sample Handler, Tecan Freedom EVO® Automated are marketed 
specifically to address sample handling variability. 26 
An interesting solution has been created for correcting labelling biases. In cases where iTRAQ 
quantitation was used, ratiometric normalization has been utilized as counteraction 
measure.91,92 The approach involves adjusting the peptide ratios to center the distribution of 
peptide ratios on 1. However, this method itself has many concerns over inaccuracy (Reviewed 
by Christoforou and Lilley93). 
Arguably the most powerful QC wet lab tools however, are QC samples. Reviewed in detail by 
Bittremieux and colleagues,94 samples can consist of single protein samples such as BSA or 




separately in a discovery analysis, but can be included in the sample if necessary. Several 
studies have also centered around creating their own proteomic spike-in standards for QC and 
evaluation of methods.95,96 
Calibration peptides, frequently referred to by the vendor’s (Biognosys) designated name of 
indexed retention time (iRT) peptides, are often used for calibrating the retention time of the 
sample.97 This is especially powerful in the case of DIA, where matching RT to that of a library is 
so critical. In addition, these peptides can also be used to gain information on the quality of the 
run as their behaviour shows increased stability in comparison to other peptides, and QC 
metrics on these peptides can therefore be very helpful. The software QuiCTM from Biognosys 
can be used to assess the quality of the run by evaluating metrics from these peptides and is 
freely available.98 
1.3.2 QC software solutions 
The quality control of proteomic discovery LC-MS has grown in the last decade to an 
established field in its own right with analysis pipelines incorporating QC metrics generation as 
part of their pipeline. Several software packages also exist to generate QC metrics in Shotgun 
data such as QuaMeter,99 QuaMeter ID-free,100 NIST-MS,13 PTXQC101, SprayQC,102 AutoQC 
within Skyline,103  Metriculator,104 OpenMS - KNIME pathway,105  Downstream analysis of the 
metrics generated by such software can be tricky due to the highly correlated, not normally 
distributed, multidimensional data that are produced. Software packages/toolkits that have been 
created to aid in statistical analysis and visualization of such metrics include SProCoP for 
generating control charts as part of a longitudinal analysis in the Skyline pipeline,106 DO-MS for 
MaxQuant data,107 MS-stats-QC 2.0 (previous versions were only designed for SRM) which can 
also form part of the Skyline package,108 and qc_analysis under the same repository as 




downstream analysis capabilities such as with rawDiag,110 iMONDB,109 SIMPATIQCO,111 
QCloud,112 pmartR,113 and statTarget - a tool for signal drift detection and correction.114 
As so many sources of variability can together impact the measurement drift, it is essential that 
this important aspect of QC be monitored and corrected if need be. Apart from statTarget, 
another tool also exists within the Proteowizard library to correct for instrument measurement 
drift and systemic bias, namely mzRefinery.82 
Most identification softwares allow the addition of modifications such as carbamylation or 
carbamidomethylation as variable modifications. Although this method will only allow the 
verification to take place after data analysis, it remains a powerful tool for verification.  
The same availability of QC software cannot be seen where DIA is concerned. One example of 
such software is QCMAP,115 which provides certain metrics for longitudinal data such as HeLa 
samples and performs statistical analyses and visualisations to display graphs such as boxplots. 
SProCoP generates longitudinal metrics and control charts for SWATH as well,106 whereas 
MSStatsQC provides a machine learning approach for the downstream analyses of the metrics 
produced by certain QC  tools such as SProCoP.108 
Most of the current DIA software are connected to a single pipeline of data analysis or for the 
more general tools, present very few metrics and very little insight into the data. There is 
therefore a significant gap for a software similar to QuaMeter, which provides a plethora of 
metrics in a universal format for further analysis. 
The reasons Shotgun QC software is not directly translatable to DIA and why DDA software 
cannot be used on DIA are all related to the inherent differences between techniques. For 
example in QuaMeter ID-free, the precursor is used for peak selection and the peak properties 
such as FWHM are calculated on those peaks. If QuaMeter ID-Free is run on DIA data, the 
software will attempt to find precursors which do not exist. Another problem is the size of the 




were mainly built around reading and storing all data from the file while running, which requires 
large amounts of Random Access Memory and storage space if run on a DIA file.  
1.3.3 Databases 
The rising popularity and immense benefits of open science and data sharing has resulted in an 
increase in datasets uploaded to repositories of late.116–118 This has led to journal policy 
changes, where journals (often especially ones with higher impact factors) now require public 
data submission119 and the creation of standards for data submission. In 2011, the 
ProteomeXchange consortium was founded to create a platform via which data submission 
could be standardised.117 The consortium currently consists of seven repositories: JPOST, 120 
PRIDE, 121 PeptideAtlas,122 MassIVE,123 PASSEL,124 Panorama Public,125 and iProx.126 As of 
10/08/2020 PRIDE had reported 11187 datasets in their archive, MassIVE reported 10487 
datasets, JPOST reported 121 datasets and iProx reported 939 projects, while PeptideAtlas, 
Panorama Public and PASSEL did not readily report the number of datasets. This wide 
availability of data enables not only a re-analyses with newer bioinformatic tools/ pipelines, but 
also an inspection of data to answer different scientific questions than the data was originally 
intended for. As the number of available datasets increase, the field of proteomics gains a 
deeper insight into the natural world and non-model organisms become easier to analyze and 
readily compare data. Similarly, an independent reassessment of results described publicly is 
made possible, information that can prove invaluable in the analysis of disputed claims. In the 
case of bioinformatic tool development, it enables the developer to test a novel tool on datasets 
from a large number of different laboratories, collected under different experimental and 
instrumental conditions. The implications for quality control (QC) are tremendous, as the quality 
and reproducibility of datasets do not need to be accepted as the word of the author any longer 
and can be verified. Hereby, a novel age in quality control begins where standards are set, 




1.4 Research goals 
It is imperative that researchers in proteomics apply quality assurance and quality control 
techniques in their experiments. This involves identifying the possible sources of variability, 
implementing proper experimental design and using QC metric-producing software on data after 
the run. Users of the DIA method currently do not have an open source program through which 
to generate in-depth quality metrics. In addition, tools such as QuaMeter are limited in their 
accessibility by requiring the user to be able to use a statistical language such as R/Python if a 
free analysis of the metrics is to be performed.  
This thesis aims to design a software tool for DIA QC metric production (named SwaMe) as well 
as a user interface for the downstream basic analysis of both QuaMeter and SwaMe (named 
Assurance). Furthermore, the use of quality metrics in the traditional sense of detecting 
underperforming runs, as well as the novel approach of using quality metrics for inspecting 
sources of variability and illustrating the importance of experimental design is demonstrated. 
There are three questions that a researcher should be able to answer about their data with the 
aid of quality metrics. Firstly, is the platform performing optimally to enable reproducible 
proteome analysis? Secondly, can the source of the variation be identified with the aid of the 
software? Thirdly, can the metrics provide documentation to support the biological conclusions 
drawn from the data? 
In Chapter 2, the use of quality metrics to decipher these questions is illustrated using 
QuaMeter ID-Free. Chapter 3 demonstrates the analysis of these questions with the novel QC 
metrics producing software for DIA, SwaMe. Chapter 4 illustrates using Assurance, the user 
interface for running and analyzing QC results for QC analysis and generating reports to fulfill 




Chapter 2: Interrogating sources of variability in 
shotgun proteomics using quality metrics 
 
2.1 Introduction 
The rising popularity of big data and large-scale analysis places special importance on 
standardised quality control (QC) pipelines. In this study, the QC pipeline for QuaMeter 
IDFree100 was assessed for multiple instrument types, fractionation strategies, and sample types 
retrospectively using published proteomic datasets from myeloid-derived suppressor cells 
(MDSCs), cellular exosomes and Mycobacterium tuberculosis (M. tb) cell lysates. Spectral 
counts were then investigated to compare conclusions. 
The cellular complexity and cell wall adaptations of M. tb cell lysates pose considerable 
challenges for protein extraction. Due to the pathogenic significance of this species,127 health 
researchers have optimized protein analysis by applying fractionation and by synthesising 
peptides to produce 97% “complete” spectral libraries.128  The fractionation techniques used in 
M. tb may each contribute to variability.  
MDSCs are a heterogeneous population of regulatory immunosuppressive cells that expand 
during chronic inflammatory conditions such as cancer and infectious diseases such as 
tuberculosis (TB).129,130 These cells have therefore been identified as potential targets in 
immunotherapeutic strategies.131,132  Although sufficient quantities of MDSCs can be obtained 
from tissue in mice and blood in humans, subsequent analysis steps can affect the populations 
of enriched MDSCs; both mechanical and enzymatic purification processes as well as isolation 




handling and cool temperatures to avoid interfering with measurement of their biological and 
functional properties. 133–135   
Exosomes have been identified as key role players mediating MDSC intercellular 
communication and immunosuppressive potency.136–138 Common MDSC enrichment techniques 
include ultracentrifugation and precipitation that may contaminate exosome samples with 
protein aggregates, salts and polymers.  These contaminants can influence post-isolation 
analysis such as mass spectrometry.139,140 
Many of the existing papers for QC and reproducibility of biological MS have limited their scope 
to LC-MS/MS experiments, thus missing the variability associated with fractionation, 
enrichment, and sample limitations.  By drawing upon a wide variety of published experiments, 
this study will detect sources of variability that have been uncharacterized by earlier work.  
Recognizing their influence on quality is key to making shotgun proteomics more robust for the 
fight against tuberculosis. 
My aim here is to demonstrate the traditional and unconventional use of quality metrics in 
detecting outliers and in inspecting the data for sources of variability. In addition, I aim to 
provide insight into and demonstrate the importance of another very important part of quality 
assurance - experimental design. A researcher aiming to perform a valuable experiment must 
take quality assurance and control into account in the experiment. This involves being able to 
identify sources of variability in their own experiment after analysis as well as identifying outliers 




2.2 Materials and methods 
2.2.1 Datasets 
This study investigates the fractionation and sources of variability of 11 published LC-MS 
experiments. Datasets were selected on the basis of connection to M. tb or MDSCs and 
exosomes (see table below). 
Table 2.1 – Datasets included in this study 




resulting in a 






Pandey141 123 RAW files PXD010956 
Mycobacterium 
tuberculosis 
Tabb142 120 RAW files PXD006843 
Mycobacterium 
tuberculosis 
Aebersold128 64 RAW files 
49 WIFF files 
PASS00886 and 
PASS00656 
MDSCs Escors143 6 WIFF files 
10 WIFF files 
32 WIFF files 
PXD001103 and  
PXD001106 
PXD000805*  
MDSCs Ostrand-Rosenberg144 6 RAW files PXD010215 
                                               







Schnölzer145 51 RAW files PXD010804 
MDSCs and 
exosomes 
Fenselau137 60 RAW files PXD006204 
Exosomes Jimenez146 72 RAW files PXD001487 
Exosomes He147 36 RAW files PXD004779 
Exosomes Liu148 54 RAW files PXD001339 
Exosomes Dobos149 48 RAW files 




2.2.2 Raw data conversion and metric generation 
 
The .raw files from Thermo Fisher instruments were converted to the HUPO-PSI standard 
format, .mzML,150 using MSConvert GUI with peak-picking selected.151 The SCIEX MS Data 
Converter produced “Protein Pilot” peak lists for SCIEX TripleTOF sets 
(https://sciex.com/software-support/software-downloads).   
By default, the SCIEX MS Data Converter (last updated in 2012) will process only one .wiff file 
for each call to the software; “AB_SCIEX_MS_Converter *.wiff” does not produce the desired 
result.  We created the following Windows “batch” file to enumerate all WIFF files in the current 
directory, converting each to mzML using the converter from SCIEX: 
@echo off 
for %%W in (c:\wiff\*.wiff) do ( 
   echo infile= %%W 




"C:\Program Files (x86)\AB SCIEX\MS Data Converter\AB_SCIEX_MS_Converter.exe" WIFF %%W -
proteinpilot MZML %%~nW.mzML /zlib /index ) 
2.2.3 Configuration for QuaMeter IDFree 
The following is an example of a quameter.cfg file for an Orbitrap or TripleTOF instrument that 
allows the m/z for a given chromatogram to wander back and forth by 0.05m/z: 
ChromatogramMzLowerOffset = .05mz 
ChromatogramMzUpperOffset = .05mz 
Instrument = "Orbi" 
MetricsType = "idfree" 
OutputFilepath = "metrics.tsv" 
2.2.4 From metrics to principal components 
The metric tables were analysed using the R statistical environment. The R scripts employed 
ten libraries to support advanced features. The full R script is available at: 
https://github.com/marinaPauw/TabbDatasetQuaMeterAnalysis. 
The libraries included “MASS”,152 which boasts a variety of statistical functions, “psych”,153 which 
contains functions for psychometric analysis, “lattice”,154 which boasts tools for creating graphs 
,“lme4”,155 a package centered around linear models ,“car”,156 which is aimed at users applying 
regression, “dendextend”,157 which offers functions for dendrograms and clustering 
visualisations, “modelr”, which contains functions for modelling, “tidyverse”,158 an entire universe 
of R functions and “ggfortify”,159 a package for data visualisation. 
2.2.5 Principal component analysis 
Metrics with a variance <1% or a Pearson correlation coefficient >99% were excluded from the 




one of the two is chosen. Robust PCA was conducted to reduce dimensionality and visualize 
the experiments. 
The robust covariance functions cov.rob() and cov2cor() were used to create the covariance 
matrix that served as input for the PCA. For reproducible analysis, the set.seed() function 
should be used with the parameter 1234 to increase reproducibility of the cov2cor() function, 
which includes a randomisation step. 
2.2.5.1 Analysis of grouping within principal components 
A standard one-way ANOVA does not account for the interaction within the hierarchy of a 
replicate structure. In this study, a mixed effects linear model was created from the first 
component in order to conduct nested ANOVA analysis.160,161  
The fraction number was considered a measurement variable, while biological replicates were 
represented as a fixed effect and the technical replicates as the random effect.  The functions 
lmer() and lm() were used to create multiple models for mixed effects models and fixed effects 
models respectively, whereafter the function r.squaredGLMM() was used to view the r-squared 
values of each of the models in order to determine the best fit. The evaluation process is unique 
for each dataset, but importantly, increasing the number of effects will almost certainly increase 
the fit, eventually resulting in overfitting. It is therefore important to critically evaluate the addition 
of components from a biological and statistical perspective.(See Heinze et al., 2018162 for 
review) The formula of the model found to be the best fit for the Tabb dataset was: 
 𝑦 = 𝑋𝛽 + 𝑍𝑏 + 𝜀  
Where:  
y is the response variable (Comp.1); 
𝑋is the fixed effects design matrix 




𝑍 is the random effects design matrix 
b is the vector of the random effects (Biological replicate, Technical replicate and date in the 
Tabb dataset) 
ε is the error vector 
 
lmer(Comp.1~Fxn +Sample+(1|Biorep)+(1|Rep)+(1|dates)) 
The formula of the model chosen for the Fenselau dataset was: 
lmer(Comp.1~EC+IC+(1|Bioreps)) 
This model was used in a nested ANOVA approach similar to Wang 2014,100 with a probability 
of less than 0.05 considered significant for the difference between the first component value for 
groups such clustering occurring by chance. Within the Fenselau dataset, the term EC refers to 
the sample type (exosomes vs cells) the term IC refers to the biological state (inflamed vs 
conventional), Bioreps indicate the mouse the sample originated from. Within the Tabb dataset 
the term Fxn refers to the fraction the sample originates from and Rep refers to the technical 
replicate, with Biorep referring to samples originating from different original single colonies. The 
ANOVA was performed for each of the first five principal components in the Tabb dataset and 
Bonferroni correction was subsequently applied. With five separate ANOVA’s analyzed, the p-
value considered significant was now 0.05/5 = 0.01. 
The sum of Akaike weights is often used to compare the relative importance of variables within 
a model.163 Similarly, all model combinations of the different parameters listed in the formulas 
above were populated. Subsequently, the Akaike’s information criterion (AIC) value for all 
models containing a parameter was calculated using broom.mixed::glance(), added for each 
parameter and compared to evaluate the parameter influence on the position of the data point in 




2.2.6 Factor analysis 
Highly correlated metrics were not removed for factor analysis and another robust correlation 
matrix was generated for all metrics with a variance of >1%. Kaiser-Meyer-Olkin measure for 
sample adequacy was performed using the KMO() function in the psych package and the 
analysis was only performed on datasets which scored higher than the cut-off of 0.60. Bartlett’s 
test of sphericity was then performed using the function cortest.bartlett() also in the psych 
package with a threshold of <0.001. Maximum likelihood was chosen as the factor extraction 
method and Varimax as the rotation method. The core function fa() was used and the analysis 
was performed with the robust correlation matrix as input. 
2.2.7 Recognizing outliers through distance 
Visual inspection with the Elbow method determined the number of principal 
components/factors to be included in further analysis. The chosen components were used in the 
calculation of the Euclidean distance matrix via the function dist().164 The distances between 
data points were used to calculate relatedness or to identify outliers. A vector was made up of 
the median distances for each point in the dataset and the interquartile range (IQR) was 
calculated. If the median distance for a data point exceeds that of Q3 + 3 x IQR, the value was 
considered an outlier. Tukey’s method was chosen rather than Z-score or modified Z-Score due 
to its relative robustness against outliers and skewed distribution. The  MADe method shows 
similar benefits and could also be utilized (For review, see165). 
2.2.8 Database search and assembly 
The Ensembl FASTA for the corresponding species in each dataset was combined with 72 
added proteins representing major contaminant proteins. Mycobacterium tuberculosis 




(both downloaded 20180308 from Ensembl 92) included 107844 and 65542 proteins, 
respectively.  
The MS-GF+ search engine (20170113 release) was employed in all cases,166 configuring the 
software to reflect the correct mass analyzer for MS/MS measurement (“TOF”, “LowRes”, or 
“HiRes” Instrument settings), precursor mass accuracy of 20 ppm for Orbitrap measurement or 
50ppm for TripleTOF, fixed mass shift of carbamidomethylation to reflect the use of 
iodoacetamide, isobaric tags for PXD001103 and PXD001106, isotopic labelling for 
PXD001339, and protease specialization for PXD010659 (see Supporting Information for 
explicit configuration file changes).  In all cases, protease specificity was required for only one 
end of the peptide, and target-decoy analysis was employed universally, with identifications 
written in mzID format.167 
2.2.9 Configuration for MS-GF+ for Thermo “Hi-Lo” experiment 
The most common database search configuration used in this paper expected MS 
measurement of peptide ions in an Orbitrap and MS/MS measurement of fragment ions in a 
quadrupole ion trap.  The call to run MS-GF+ looked like this: 
java -Xmx8000M -jar /usr/bin/MSGFPlus.20170113/MSGFPlus.jar -s mzMLs -mod Mods.txt -d 
database.fasta -t 20ppm -m 3 -inst 1 -tda 1 -ntt 1 




The most common adaptations to the configuration supported high resolution MS/MS 




50ppm precursor accuracy for TripleTOF (-t 50ppm) and 20ppm precursor accuracy for Orbi 
measurement of precursors (-t 20ppm).  These were not optimized values, but they should allow 
for acceptable identification even if the mass calibration of instruments was needed. 
The Escors set required iTRAQ configuration, resulting in a change to the command line (-




The Liu set incorporated SILAC-labeled amino acids.  While the command line required no 
special options, the Mods.txt file incorporated different lines depending on whether the 







Finally, identifying peptides in the Asp-N cleaved, biotin-labeled RAW files from Dobos 
(specifically PXD010659) required changes to the command line for the protease and 








IDPicker 3.1 build 18172 imported raw PSMs to produce a single assembly spanning all MDSC 
sets, another assembly spanning all human exosome sets, and another assembly spanning all 
M. tuberculosis proteomes.166 Protein parsimony was applied only in the context of the sample 
class rather than for each study individually.  The PSM FDR was set to 0.5%, and the number of 
spectra required per protein group was increased until the empirical protein FDR fell below 5%.  
Isobaric reporter ion intensities were not imported into IDPicker for quantitation as isobaric 
labelling was not the focus of this study. 
2.2.10 T-test comparison of two samples 
Comparison of the individual metrics between two different sample groups as well as 
comparison of peptide counts between two samples was conducted using the Welch's t-test 
using function t.test() in base R. Normality was tested using the Shapiro-Wilk test (shapiro.test() 
function in base R).  Homogeneity of variance was tested using Bartlett’s test (bartlett.test() in 
base R). As these assumptions were not violated, a non-parametric alternative was not used. 
Bonferroni correction was applied as three t-tests were conducted so the p-value considered 
significant was now 0.05/3 = 0.0167. 
2.3 Results 
2.3.1 Mycobacterium tuberculosis protein analysis 
2.3.1.1 Overlap of distinct peptides from different studies 
Identified protein counts are often used by researchers as an indication of the quality of a mass-





The M. tb proteome was analyzed from three datasets using a pipeline of MS-GF+ and 
IDPicker.  The relative insensitivity of the Tabb GeLC-MS experiments yielded 13,769 distinct 
peptides rather than the 67,248 from Aebersold and 44,660 from Pandey.  37.3% of all detected 
peptide sequences were observed in both Aebersold and Pandey (Fig 2.1). In the case of the 
dataset originating from the Pandey group, the high levels of sensitivity were achieved by 
applying four different fractionation strategies and the peptide identification counts are relatively 
similar between different strategies. Surprisingly, only an 8.5% overlap was found between all 
four techniques. 
For the Aebersold dataset, OFFGEL was the chosen fractionation technique for both 
instruments. The TripleTOF showed higher distinct peptide count and a slightly higher unique 
protein count compared to the Orbi XL, however it should be noted that the OrbiXL is much 
older technology than the TripleTOF 5500. In addition, the TripleTOF identified 387415 spectra 
for 45033 distinct peptides, whereas the OrbiXL identified 145693 spectra for 36770 distinct 
peptides. Both techniques therefore resulted in redundant spectra. The synthetic peptide 
analysis proved the highest distinct peptide count that was only found in that technique. 
Contrary to the small overlap seen in the peptide analysis (12.2%), the different techniques 
applied by the Aebersold study showed 80.3% overlap in the proteins identified. The synthetic 




A  B  
C   
Figure 2.1 – Venn diagrams of distinct peptide counts of A) All M. tb datasets (Aebersold, 
Pandey and Tabb); B) The analysis techniques applied by the Pandey group; C) The different 
analysis techniques applied by the Aebersold group. 
 
Ensembl lists 4036 protein coding genes for M. tb H37Rv. The Aebersold study identified 3873 
distinct protein groups, indicating their method development to improve sensitivity was helpful. 





2.3.1.2 Demonstration of outlier detection methods 
A critical part of any QC analysis of data is recognizing outlier experiments. Previous studies 
have employed  a supervised,168 semi-supervised,169 or unsupervised machine learning 
approach.170 In this article, we started with a simple evaluation of distinct peptide counts and 
compared it to an unsupervised approach, PCA with  Euclidean distance computation.171 We 
utilized the Tabb dataset for the demonstration. 
The dataset contains 120 RAW files from twelve GeLC-MS experiments divided into ten 
fractions each.  Tukey’s 3 x IQR criterion recognized three of the fraction 10 runs (SW1-2,SW2-
1, SW2-2) and one of the fraction 9 runs(SW2-1) as outliers based solely on distinct peptide 
counts.  As a result of the absence of a block design or randomisation structure, the diminished 
IDs of fractions 9 and 10 of GeLC-MS SW2-1 are very unlikely to be independent events. 
The Euclidean distance matrix created from the PCA of the ID-Free QC metrics171 highlighted 
two of the outliers identified by peptide counts (Fig. 2.2) based primarily on MS1-TIC-Change-
Q3 and MS1-TIC-Q1:3 metrics which suggests electrospray ionization instability. The internal 
RAW file dates reveal a 23 day period between these two LC-MS/MS experiments and the next 
GeLC-MS. Subsequent RAWs did not separate from the rest of the dataset (Fig. 2.3). Evidently, 






Figure 2.2 – PCA of Tabb dataset. Polygons indicate the GeLC-MS replicates. Two experiments 
were identified as outliers by identification data only (red) and two more were identified by aPCA 
of the quality metrics (black).  The naming structure indicates M. tb strain (H37Rv, SAWC3517 







Figure 2.3 – Samples run on different dates grouped together for the Tabb study. Note that the 
samples run on the last two days return to the larger data group. 
2.3.1.3 Investigating the influence of fractionation techniques on variability 
Fractionation is known to introduce variability in proteomics,172–174 and we therefore studied the 
impact of fractionation on quality metrics. In the Tabb dataset, instead of observing strains or 
technical replicates grouping together, we observed grouping of similar regions across gels 





Figure 2.4 - Similar fractions of different samples group together for GeLC-MS dataset in the 
first two principal components. The mean of each factor group is used as the centroid for each 
cluster.  
 
Nested ANOVA run for each principal component identified as necessary by the elbow method 
show the gel region to be the factor with the highest influence on the first four principal 
components.The p-values from the nested ANOVA were: <2e-16,<2e-16,4.107e-12,2.882e-10 
and 0.1373 for component 1:5 respectively. The first four were therefore lower than the 0.01 
value considered significant. However, when the sums of AIC weights were calculated, the 
technical replicate from which a run originates showed a higher relative importance than the 
fractions.  In this case, comparing quality metrics of a fraction to the same fraction in another 
sample is preferrable above comparing different fractions. If fractionation as a source of 
variability is ignored, the differences between runs may be misconstrued to be linked to 




The nested ANOVA revealed that the distance within the first principal component between 
each specimen of the same sample type is significantly shorter than the distance between the 
specimen and specimen of a different sample type with a p-value of 2.734e-08. However, this is 
only true of the first principal component, not of any of the other four of the first components.  To 
ascertain whether these results would hold up in a different statistical technique, linear models 
were also created for the PCA results and the sum of AIC weights compared for each variable. 
When inspecting the sum of AIC weights for each variable, the date on which the experiment 
was run appeared to play a larger role in the position of each run in the realm of the first 
principal component than the sample type.  
 
We were surprised to see particular gel regions producing an unusual pattern in the RT.TIC.Qx 
metrics (Fig. 2.5A). The trend is especially prevalent in SAWC3517, one of the three strains 
investigated by the study. This set of metrics describes the proportion of all TIC that is 
accumulated during each quartile of retention time for a given LC-MS/MS experiment. As the 
four values sum to 1 (all TIC observed in a given RAW), a stacked bar plot of the different 
quartiles for this metric effectively visualizes the distribution of the TIC.   The IDPicker results 
have been visualized in Fig. 2.5B as a point of comparison. For the region with the highest 
diversity(later sections of the gel), the majority of signal is located in the third quartile of the 
retention time. Such information displays the reproducibility in the analyst’s technique and could 
be used to optimize the method for sensitivity by including a higher number of fractions in the 







Figure 2.5 A–Similar fractions showed similar RT.TIC patterns in this SDS-PAGE fractionated 
dataset. The colours indicate the proportion of RT taken to collect each quartile of the TIC. The 
middle fractions appear to have taken longer to collect the second and third quartile of the TIC. 
B -Similarly, the number of filtered PSMs, distinct peptides and distinct matches in the data 
shows a distribution pattern around the different fractions, fraction seven or eight generally 







2.3.1.3 Discerning different experimental parameters and methods 
In the Pandey study,141 a number of different fractionation strategies were employed. Cell 
lysates were fractionated via GeLC-MS, MudPIT or OFFGEL isoelectric focusing (IEF)(Fig 2.6A) 
and with experimental settings comprising of either ion trap (ITMS) or Fourier transform (FTMS) 
combined with collision induced dissociation (CID) or higher energy collision induced 
dissociation (HCD) (Fig. 6B). The fractionation strategies showed differences in their resulting 
peak widths (XIC-FWHM-Q3), with cell lysate in gel showing the widest peaks and the Off-Gel 
strategy generating the highest number of distinct peptides. The data collected via CID-ITMS 
showed a lower rate of MS2 acquisition and an increased peak width. The Pandey set offers a 
diversity in MS/MS acquisition strategies that are distinguishable from each other by QC metrics 







         
 
Figure 2.6A – The first two principal components of the Pandey dataset175 grouped by different 
instrument parameters( F= FTMS, I = ITMS, green = CID, purple = HCD). B - The first two 






Similarly, ID-Free metrics are more than sufficient to discern differences between TripleTOF and 
Orbitrap experiments as well as the difference between peptides originating from cell lysate or 
synthetic peptides (Fig. 2.7) in the Aebersold dataset.  
 
 
Figure 2.7 - PCA of the Aebersold dataset.128 Data are grouped by protein origin (S = Synthetic 
peptides, M = M. tb cell lysate) and the instrument used (colour). 
 
The M. tb cell lysates contained fewer peptides than synthetic peptides. The quality metrics of 
the OrbiXL show higher peptide density (MS2-Density), but lower acquisition speed than the 
TripleTOF (MS1-Freq.Max and MS2-Freq.Max). T-test results were as follows: 
The Welch’s t-test results for comparison of MS1 Freq Max and MS2 Freq Max between 




Welch Two Sample t-test 
data:  metrics$MS1.Freq.Max[1:63] and metrics$MS1.Freq.Max[64:101] 
t = -9.945, df = 37.418, p-value = 4.714e-12 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -1.4032848 -0.9284037 
sample estimates:mean of x mean of y  
 0.942034  2.107878  
Welch Two Sample t-test 
data:  metrics$MS2.Freq.Max[1:63] and metrics$MS2.Freq.Max[64:101] 
t = -8.5658, df = 37.576, p-value = 2.299e-10 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 -5.199781 -3.211227 
sample estimates:mean of x mean of y  
 2.693013  6.898517  
Welch Two Sample t-test 
data:  metrics$MS2.Density.Q3[1:62] and metrics$MS2.Density.Q3[63:101] 
t = 17.479, df = 87.486, p-value < 2.2e-16 
alternative hypothesis: true difference in means is not equal to 0 
95 percent confidence interval: 
 567.3946 712.9826 
sample estimates:mean of x mean of y  




2.3.1.4 Factor analysis 
QuaMeter metrics are often highly correlated. PCA assumes that the components created are 
independent, something that is easily achieved if data is Gaussian, but can often become a 
problem if variables are highly correlated.176  Therefore an appropriate alternative dimensionality 
reduction method to PCA.  
When applied to the dataset mentioned above,142 the visualisation of the first two factors was 
quite different from when PCA was applied (Fig.2.8A). The clustering of similar fractions was not 
as strong as with PCA. In addition, FA was unable to detect any anomalies, possibly due to the 
metrics in which the outliers showed different values to the rest of the dataset, not having been 
grouped in the same underlying factors (Fig. 2.8B). A researcher must therefore be cautious if 
only including factor analysis as the main dimensionality reduction method, as it may mask 
outliers in data quality. 
 
Figure 2.8 – A - Factor analysis of the same dataset which generated Fig. 2. 14 Note that 
although some of the similar fractions still group together, the association is much less strong. 





2.3.2 Protein analysis of MDSC’s and their exosomes 
2.3.2.1 Investigating identification data 
The four MDSC experiments we feature enriched for a very small subpopulation of immune cells 
in murine models. The Ostrand-Rosenberg set was published in  2011,144  employing older 
equipment and only six LC-MS/MS experiments.  Understandably, 75% of all its identified 
peptides were also identified in one of the other three sets (Fig. 2.9).  The Escors experiment, 
on the other hand, was the only TripleTOF-powered lab among the MDSC experiments.  
Approximately half of its peptides were identified only by this team. The anatomical location may 
also influence the protein content and phenotype,134 so it is important to note that Escors and 
Schnölzer experiments obtained MDSC’s from bone marrow, whereas Ostrand-Rosenberg and 
Fenselau datasets obtained MDSC’s from blood. Amongst the MDSC datasets, there was not a 
large discrepancy between Escors, Fenselau and Schnölzer datasets regarding their distinct 
peptides. The Ostrand-Rosenberg set,144 conducted long before the rest using older equipment 
and only six replicates, resulted in only 3.2% uniquely identified distinct peptides and only 0.1% 
unique proteins identified. The incorporation of technical replicates resulted in a large number of 
identified spectra for the Fenselau dataset (270270), although these spectra only resulted in 
11805 distinct peptides in total and 121 unique proteins. Perhaps the incorporation of 
fractionation techniques would have resulted in a higher distinct peptide count. Of these 
datasets, once again the dataset which used a TripleTOF (QTOF) as the instrument resulted in 





      
Figure 2.9 - Distinct peptides identified for each MDSC dataset present included in the analysis.  
 
2.3.2.2 Sample type influences QC metrics 
When Myeloid derived suppressor cells (MDSCs) are investigated along with their exosomes, 
QuaMeter ID-Free is able to distinguish the sample types from one another in the realm of the 
two most important principal components (Fig. 2.10A). It should be noted that in both datasets, 
the samples were sequentially run and that the dates of the experimental runs follow the same 
trend, although not exactly separating in the same manner.  The second dataset included 
CD11b+Gr1+ Spleen Cells and MDSCs each with corresponding exosomes. The different 







Figure 2.10A - PCA plot showing myeloid derived suppressor cells (MDSCs) and their 
corresponding exosomes. Note the separation of the two sample types in the realm of the first 
two principal components. B - In another dataset, the effect was much less pronounced and the 
separation of samples and their exosomes not as clear.  
 
2.3.3 Exosome protein analysis 
2.3.3.1 Peptide overlap in the exosome datasets 
The exosome datasets (Fig. 2.11) show great disparity amongst the projects. It must be 
remembered that the datasets include exosomes originating from different cell types. Of the 
total number of unique peptides, 77% were identified in the more recent Jimenez dataset.146 
This study incorporated the exosomes of acute myeloid leukaemia blast cells, which generally  





Figure 2.11 - Distinct peptides identified by each exosomes study in the analysis. 
 
2.3.3.2 Fractionation does not always improve sensitivity 
In the Liu exosome dataset,177 samples were either subjected to GeLC-MS/MS or SDS gel 
direct embedding without electrophoresis. After PCA, the fractionated and unfractionated data 
separated completely in the realm of the first two principal components regardless of the 
replicate the sample belonged to, indicating that fractionation played a larger role on the quality 
metrics than any other step in the method. MS1Density (the number of peaks present in the 
MS1 scan) was the metric that demonstrated the greatest change; one naturally expects that 
fractionated samples will show smaller numbers of peptide ions in each MS scan. 
Studies often report the number of identified peptides from fractionated data as 21 times,173 or 
even 43 times174 higher than unfractionated data. However, in the Liu dataset, the combination 
of all fractions of one particular sample did not achieve as high distinct peptide identifications as 
the unfractionated version of the same sample (Table 2.2). The total distinct peptides identified 
from fractionated samples and unfractionated samples were not significantly different for this 




Table 2.2– IDPicker identification data comparing the total of all distinct peptides from all the 












 3519 6292 34641 3 602 
Total of Fractionated samples 3080 5579 27311 3 589 
Total of all fractions for sample A 1847 2641 8094 3 482 
Total of all fractions for sample B 2458 4408 11833 3 554 
Total of all fractions for sample C 627 802 2648 3 259 
Total of all fractions for sample  D 976 1589 4736 3 341 
Total of unfractionated samples 1220 1744 7330 3 301 
Unfractionated A 927 1247 2055 3 234 
Unfractionated B 628 937 1594 3 177 
Unfractionated C 764 1096 1894 3 202 
Unfractionated D 701 1004 1787 3 188 
 
2.3.3.3 Evaluation of different digestion enzymes 
The Dobos dataset included the application of different enzymes. MDSCs were either digested 




period separated the two experiments, contributing a substantial batch effect to the QC analysis.  
51.1% of the proteins identified in the study were only found in the samples digested with 
trypsin, with 46.2% identified in both trypsin and Asp-N digests and only 2.6% were uniquely 
identified in the samples that were digested with Asp-N (Fig. 2.12). Due to its popularity, a large 
amount of optimization has been performed over the years to give trypsin the advantage. The 
smaller inventory of proteins from Asp-N in this study could therefore reflect a less-optimized 
protocol for the rarely used enzyme.  
 
Figure 2.12 – Dataset where two different enzymes were used due to biotinylation of lysine 
residues. Note that the different enzyme datasets were analyzed with a five-month gap in 
between (Diaz et al., 2016).   
 
2.3.3.4 Importance of experimental design 
Most of the datasets in this study applied a sequential analysis pattern, without blocking or 
randomisation. However, Jimenez and He datasets did apply a block design to their 
experimental plan.146,147 The Jimenez dataset applied SDS-PAGE fractionation to divide 
samples into 9 fractions. Similar fractions were then run sequentially, starting from fraction 1. 





Figure 2.13 – In this GeLC-MS dataset from the Jimenez group, the data was run more or less 
in a block design, with the same fraction of different biological samples run sequentially. Note 
that all the runs of a particular date separate from the rest of the experiment (08042018) in B). 
Those samples correspond to fraction 9 of a number of different samples, therefore the effect of 
the separation was spread out over different biological samples. 
 
 
The block design enabled the researchers of the He study to avoid batch effects by not running 
fractions from the same biological group concurrently. Three samples run sequentially at pH 4 
showed a higher MS1.TIC.Change.Q3 than the other three specimens, indicating that for a 
period in time, the ionization was less stable. However, due to their experimental design, the 








Figure 2.14 – The first two principal components visualized for the He dataset. Note that the 
data cluster in groups of three, corresponding to the order in which the experiments were 
performed, as well as to the different pH fractions were eluted at. The samples were run in a 
block design, avoiding batch effect. 
 
 
Figure 2.15 – The MS1.TIC.Change.Q3 metric showed increased values for some of the runs, 
indicating ionization instability. The effect is spread out over the second technical replicate of all 
three biological replicates. If the block design had not been applied, two replicates of the same 





These findings indicate that the three principles for experimental design proposed by Fisher178 
(namely replication, randomisation and block design) help compensate for minor instrumental or 
technical anomalies within the dataset whilst still producing reproducible results. They illustrate 
that quality metrics are useful in ascertaining the comparability of fractionated proteomics 
experiments in an unbiased manner. 
2.4 Conclusion 
In this study, datasets investigating the complex sample types of M. tb and cells and exosomes 
from the innate immune system of mice or humans were analyzed to illustrate the use of quality 
metrics to interrogate different stages of the Shotgun workflow.  The use of PCA to conduct 
multivariate analysis demonstrates an under-used avenue for exploring quality metrics. The 
nested ANOVA approach illustrates the fraction (or SDS-PAGE gel region) of origin for spectra 
for one of the datasets had a larger influence on quality metrics than the technical or biological 
replicates the sample originated from. Another dataset saw fractionated and unfractionated 
samples completely separating in the space of the first two principal components. Fractionation 
is therefore an integral source of variability that should be considered in experimental design 
and possibly included in blocking structure. This study has highlighted several parts of an LC-
MS/MS experiment as sources of variability, including fractionation technique, sample type, 
mass analyzer fragmentation method combination, enzyme used for digestion and instrument 
type.   
Lastly, we found that although many of the studies did employ replication, only two studies out 
of the 11 incorporated blocking/randomisation in their experimental design. These two datasets 
illustrate that a well-designed experiment can overcome minor technical anomalies that are to 





Chapter 3 : SwaMe - quality control for DIA mass 
spectrometry 
3.1 Introduction  
LC-MS/MS is highly complex, and yet data are not captured for the performance of each aspect 
of the technology in isolation.  The intensities measured for a given m/z at a given retention time 
must be interrogated closely to detect, for example, a distortion in the liquid chromatography.   
Software tools used for retrospective QC analysis must therefore provide maximum possible 
insight to each source of variability.  
There are two main acquisition techniques in proteomics. Data-dependent acquisition (DDA)5  
where the full scan (MS1) is used to select a subset of peptides that are subsequently and 
separately fragmented and analyzed in MS2. Data-independent acquisition (DIA) involves the 
fragmentation of sequential isolation windows of 3 to 25m/z in size.8 DDA suffers from an 
inherently stochastic selection process in the selection of peptides to fragment leading to high 
number of missing values in particular at the low abundance range where, from a biology 
perspective, a high percentage of proteins of interest are present. DIA’s  greatest disadvantage 
on the other hand could be in dealing with the complexity of this data-intensive technique in 
order to ensure low levels of false spectrum matches.  
Although in-depth quality analysis of DDA metrics is possible via tools such as QuaMeter99 and 
QuaMeter ID-Free,171 the same luxury was not available for DIA analysis. Due to inherent 
differences between DDA and DIA, using a DDA tool for DIA analysis results in random ions 




has unique challenges. For example, there are additional factors such as isolation window 
structure84,86  that may influence the variability between samples. 
The aim of this study is to create a cross-platform, instrument independent, free software that 
produces QC metrics from DIA data, named SwaMe. I aim to use this software to demonstrate 
how a researcher may be able to answer two key quality questions about their data.  
Firstly, I answer the question whether there are any outliers in the run. Secondly, I answer the 
question of whether a researcher can determine the main source of quality variability from their 
experiment results, using SwaMe. Thirdly,, I answer a question that the instrument operator/ 
quality scientist might ask, namely whether one can be alerted to impending instrumental 
breakdown by viewing the metrics produced by SwaMe. 
 
3.2 Experimental section 
3.2.1 Datasets 
Datasets were chosen to represent three different instrument vendors (SCIEX, Thermo Fisher 
and Waters), as well as a variety of sample types such as cells of bacterial, fungal and human 
samples, which include urine and tumor tissue. In addition, FFPE tissues were represented as 
their impact on quality studies has previously been noted.29 Three of the datasets are publically 





Table 3.1 – Datasets included in this study 











36 WIFF files PASS00655 




Q-Exactive 12 Thermo 
RAW files 
PXD010934 


















Homo sapiens pediatric 
urine samples 
Steen Q-Exactive 64 Thermo 
RAW files(32 
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3.2.2 File conversion 
The .raw files from Thermo Fisher and the .wiff and .wiff.scan files from SCIEX instruments 
were converted to the HUPO-PSI standard format, .mzML,150 using ProteoWizard MSConvert 
command line with peak-picking set to true.185 For Waters .raw files, MSConvert peak-picking 
was not employed. 
3.2.3 Metric generation 
SwaMe is a set of software packages created specifically for the QC of proteomic DIA LC-
MS/MS data within the Yamato software framework. This framework consists of multiple 
parsers. The most important of these enables extremely fast forward-only parsing of an mzML. 
SwaMe consists of SwaMe.Core and SwaMe.Prognosticator packages that complement each 
other for the QC analysis of DIA and are combined to produce a single output file for further 
analysis with a statistical tool. These functions are accessed via a command line interface, 
SwaMe.Console. 
A key design principle of SwaMe is to produce metrics as near to data acquisition time as 
possible (instead of relying on slow post-hoc analysis), allowing for near real-time analysis of 
samples. A robust command line interface is intended to automate quality control of samples as 
they are produced by the LC/MS platform. Metrics are presented as a HUPO-PSI mzQC file,186 
which boasts a JSON format for increased readability and lower memory requirements whilst 
also storing metadata. A structured schema and controlled vocabulary enables information such 
as the metric name and description to accompany the value, aiding interpretation and allowing 
comparison between software tools. 
SwaMe was modelled after an ID-Free “shotgun” QC tool, QuaMeter.171 One key difference is 
that metrics in SwaMe are separated into three different groups: RT-divided, m/z-divided (by 




opportunity to provide a value corresponding to the number of segments that the RT is then 
divided into. Therefore instead of providing one value for the entire RT, the user is presented 
with a value for each segment of the RT. This section includes metrics that are chromatography-
related such as MS2PeakWidth and TailingFactor. There are also general metrics such as the 
AvgMS2Density and DeltaTICAvg that can provide insight into the distribution of these metrics 
across the RT. 
Each metric in the SWATH-divided section provides a value for every unique target isolation 
window or “swath.” These include metrics such as the AvgProportionOfTotalTIC which adds the 
TIC for all swaths of the same target m/z together and then works out the proportion of the total 
TIC made up by this swath. The swathDensityAverage describes the number of ions on average 
detected in a swath with the target m/z range in question and similarly the swathDensityIQR 
calculates the interquartile range of this metric for the particular swath. This section provides 
information as to the distribution of the metric across the m/z axis. 
The comprehensive metrics each provide only one value per run. These metrics include the 
number of scans such as in MS2Count, the number of ions detected in the MS2 scans in the run 
such as in totalMS2IonCount as well as a metric reporting the number of scans without any data 
points.  
As part of Addendum A, a full table of the metrics is provided. 
For Aebersold,128 Hembrough,183 Pereira,184 and Stoychev datasets, SwaMe was run with the 
following arguments: tolerance of 0.05m/z, retention time-divided metrics were divided into 
deciles (divisions=10), minimumIntensity of 100. For Pereira,184 the minimum intensity was 
adjusted to 1. For outlier detection in the Stoychev dataset, the divisions were set to 1 and the 




them. The comprehensive metrics and the RT-divided metrics were then combined to form one 
larger table that could be used as input for a robust PCA. 
Downstream analysis was performed in the statistical environment R.   
Orthogonal to the core SwaMe metrics, SwaMe.Prognosticator metrics were created by 
collaborators from University of Manchester. Although SwaMe.Prognosticator forms part of 
SwaMe, analysis of results can occur independently and as it was created by our collaborators it 
will not be discussed in this thesis. 
3.2.4 Principal component analysis for outlier detection 
Each type of metric (metrics provided for each m/z target window, each segment of the RT or 
metrics provided for the entire experiment) was analyzed separately for each experiment. First, 
metrics with low variance (<1%) and high correlation (>99%) were excluded as no new 
information would be provided by such metrics. 
For Aebersold, Hembrough, and Pereira, the number of files were too few to enable a robust 
PCA, and a PCA was performed using the base R function, “prcomp”, with scaling set to true.  
However, in the Stoychev dataset this method could be conducted similar to what has been 
described previously.100  
3.2.5 Identifying outliers through distance  
The Elbow method determined the number of principal components/factors required to 
characterise quality metrics.163 The chosen components were used in the calculation of the 
Euclidean distance matrix via the function “dist”. The distances between data points were used 
to calculate relatedness or to identify outliers. A vector was made up of the median distances for 




distance for a data point exceeds that of Q3 + 3 x IQR, the value was considered an outlier (As 
reported previously187).  
3.3 Results and Discussion 
3.3.1 Introduction 
In this study it was important to include publicly available datasets from different instrument 
vendors to illustrate the versatility of the software toolset and to bring to light the availability of 
data from different vendors. Although Sciex and Thermo Fisher instrument data forms the 
majority of data available in the ProteomeXchange117 repositories, we were pleased to find data 
from Synapt-MS instruments. The number of MS^E datasets with the keyword “MSE” listed at 
the time of submission in ProteomeXchange was only 33. PRIDE121 listed 47 datasets from a 
Synapt instrument and MSE as keyword. Panorama public125 only contained one dataset with a 
Synapt instrument and MassIVE123 showed 9. The same keywords when input into OmicsDI188 
resulted in 87 matches for PRIDE and only 1 match for MassIVE. Although the percentage that 
these datasets make up out of the group of scientists that utilize MSE technology is unknown, 
the scientific community could definitely benefit from an increase in the total number of publicly 
available datasets from Waters instruments using this technology for acquisition.  
With the increased analyses of big data as well as the increased size of DIA files compared to 
early technologies such as DDA comes the need for faster analysis. Parsing speed was 
therefore a priority and on a 64-bit i3-3217U laptop with 8GB of RAM the analysis was able to 
complete in 53s for a standard 3.5GB mzML file from the Stoychev dataset.  
3.3.2 Investigating window isolation scheme with QC metrics 
The metrics that are provided per SWATH (therefore metrics are averaged for each window with 




axis. The Aebersold dataset182 included 32 sequential windows that were a fixed size of 25m/z 
each. If PCA is performed on the SWATH metrics, it is clear that metrics of the same isolation 
window cluster together in the space of the first two principal components, indicating the large 
impact that the m/z of a precursor has on QC metrics (Fig. 3.1A). This behaviour follows what 
might be expected of a fixed window structure where the ion distribution is not equal between 
different windows of the same scan. The shape of the PCA results akin to the less than sign can 
be attributed to the windows at the start of the cycle displaying an increased proportion of total 
TIC to the middle and end of the cycle, whilst swaths in the middle of the cycle show a higher 
average density and IQR for the density compared to the swaths at the end and beginning of 
the cycle. The swaths at the end therefore had lower TIC and lower average density. 
In the Hembrough dataset,183 a staggered isolation window scheme was implemented similar to 
previous studies.85,189 Twenty-one fixed, sequential, non-overlapping windows with a width of 
20m/z covered the m/z range, only to be followed by the same scheme with each window target 
m/z offset by 10m/z. This method allows detection of the ions that were at the edges of the 
windows in the first half of the cycle and has the added benefit of a decreased cycle time 
compared to conventional overlapping window schemes. After 42 windows had been collected, 
the cycle was restarted. Despite what is mentioned in the article, the mzML files show no 
evidence of an MS1 scan being collected. The TIC and average density for the two halves of the 
cycle show equal average densities and equal proportions of the total TIC. The researchers 
therefore were able to gain viable peptides from both offsets. SwaMe does not utilize 
identification, so it is unclear if the number of distinct peptides detected by the two halves of the 
same isolation window scheme differ. This trend once again shows the strong impact that the 



















Figure 3.1A - PCA of the swath divided SwaMe metrics of the Aebersold dataset.128 Each 
datapoint represents one unique isolation window within the run. B - Proportion of TIC for the 
entire experiment that was collected by SWATHs of the same target m/z of the Hembrough 
dataset.183 Notice the unique isolation scheme of 21 sequential windows followed by the same 






3.3.3 Troubleshooting problematic data with quality metrics 
In the Steen dataset, 32 samples were run before a turbo-pump failure prompted researchers to 
halt the experiment. After replacing the pump, the same samples were rerun. This dataset is 
perfect for analysis with SwaMe, where the run can not only be analyzed by itself, but also 
compared with the reruns after.  
 
When viewing the average MS2 density for the different segments of the RT in the Steen trial 
dataset prior to turbo-pump failure, a pattern emerges of a delayed bell curve with an apex 
around segments 5-8 (Fig. 3.2A). However, unexpectedly, the average MS1 ion density does 
not show a clear pattern, with many samples showing a very low density in MS1 scans, others 
only reaching a density of 500 ions detected after segment 8, while some never dropped below 
500. When comparing the trial and rerun values for this metric, we see that this initial decrease 
in ions detected was unique to the trial run (Fig. 3.3A). In addition, although the second to last 
run sample did not deviate from the usual trend seen in the rerun, most of the deviations 
occurred in close temporal proximity to the pump failure (Fig. 3.3B). This trend is not reflected in 
the total MS1 (Fig. 3.2B) or MS2 TIC (Fig. 3.2C), nor does the change in TIC from one scan to 
the next (Fig. 3.2D) show much deviation from the total TIC as one would expect with ionization 





Figure 3.2 - The unpublished Steen trial dataset shows a consistent pattern amongst the 
samples for the A) average MS2 density over the RT segments. B) The TIC of all MS2 scans 
does not follow the same trend as the density with a sharper initial incline, indicating that 
initially, a small number of ions are making a major contribution to the intensity. C) The log of 
MS1TIC Total follows a very similar trend to MS2 TIC Total. D) The log transformed change in 
TIC from one MS2 scan to the next shows a trend similar to the TIC, indicating that ionization 













Figure 3.3A - The average MS1 ion density for the trial and rerun of the Steen dataset. Notice 
how the rerun dataset group into a consistent pattern, indicating that the number of ions in an 
ms1 scan were not supposed to show an initial drop as they did in the trial run. B - Line graph to 
highlight the run order of samples that deviated from the trend(coloured lines) opposed to lines 
that follow the trend (black). Run order was sequential for the naming structure, with H19 as the 
first sample and H51 as the last sample run. From this figure we note that although most out of 
trend samples were run in the latter half of the experiment, not all samples run close to the end 






The visualization of a PCA of the combination of trial and rerun data was performed separately 
for the different RT segments (Fig. 3.4A). The first segment of the RT, the trial and rerun data 
separate so clearly in the space of the first two principal components that an imaginary line can 
be drawn between them. In the other segments the separation becomes less pronounced as the 






Figure 3.4 - The first two principal components of the first (A = RT segment 1) out of ten 
segments of the RT containing both the runs for the trial (red) and the reruns (blue). Notice the 
separation of the trial and rerun data. As the RT progresses (B:J = RT segments 2:10), the 
separation between the trial and rerun groups becomes less clear.  
 
This data suggests that the difference between the trial and rerun samples is most pronounced 
at the beginning of the run and the MS1 scans of each cycle show a lower density than 
expected. The absence of this particular trend in the TIC metrics could be an indication that the 




subsequently the TIC is not affected to such a large degree. The difficulty that the turbo pump 
was having in maintaining pressure appears to have resulted in fewer ions proceeding to the 
detector. The vacuum in the orbitrap compartment also changes when the HCD is switched 
on,190 which could explain the problem diminishing in MS2 scans as the HCD has been switched 
on. SwaMe metrics were therefore able to reflect that the turbo-pump failure resulted in an 
inconsistency in the number of ions that were able to reach the detector, especially at the 
beginning of the cycle when the HCD was not yet turned on, without affecting the ionisation or 
TIC. This case also highlights the usefulness of segmenting the RT. 
 
3.3.4 Scrutinizing outliers for the dataset as a whole 
The Stoychev dataset was run prior to the invention of SwaMe. As part of their QC analysis of 
the data, several runs were identified as candidates to be rerun. 
List of files rerun after manual curation of the Stoychev dataset: 
003_1, 003_2, 013_1, 013_2, 056_1, 058_1, 058_2, 184_1, 184_2, 186_1, 186_2 
 
The selection was based on comparison of MS2 fragment intensities among injection replicates 
(Fig.3.5) excluding anything with a CV higher than 20%, as well as the percentage of the library 
matched by each SWATH, with 10% as the minimum cut-off. 
 
For this study, I decided to illustrate and compare the identification-free outlier analysis with 
SwaMe with their approach. For outlier analysis with SwaMe, the Stoychev dataset was rerun 
without dividing the RT into segments in order to include the RT metrics in the PCA for outlier 
analysis. PCA and distance based outlier detection revealed one outlier in the original dataset, 






















Figure 3.5A - PCA of Stoychev dataset where a sample (013_2) has been identified as an 
outlier. B - A line plot of the peak widths for RT segment 1-6 show this sample has a lower value 
for segment 2 and segment 5 than the other samples in the experiment. 
 
Some of the metrics that proved responsible for the segregation of the outlier include 




metrics such as MS1TICTotal and MS2TICTotal, as well as density related metrics such as MS1 
and MS2 average density (Fig. 3.6).  
 
Figure 3.6 - PCA with loadings for comprehensive metrics from the Stoychev experiment. 
The 11 samples identified for rerun by the Stoychev laboratory using their own approach were 
highlighted here in pink. The run, 013_2 that was identified as an outlier candidate in SwaMe 
outlier analysis was one of those selected originally by the Stoychev laboratory.  Upon viewing 







 Figure 3.7 - MS1(A) and MS2TICTotal(B) from the Stoychev dataset with the samples selected 
for rerun displayed in blue. Purple lines indicate Q1 and Q3 and the red lines indicate Q1-1.5 x 
IQR and Q3+1.5 x IQR respectively. Samples 013_1, 013_2, 186_1, 186_2 showed TIC total 
values on the lower end of the metric, which contributed to their selection for rerun. Although 
013_2 is not eligible as a possible outlier with Tukey criteria, in both cases the file has a lower 
value than the others.  
 
Of the total list of samples selected for the rerun 013_1, 013_2, 186_1 and 186_2 show a lower 
MS1- and MS2TICTotal, as well as a lower MS2Density50, indicating that fewer ions were 




average density of a MS2 scan (Fig. 3.8), the difference between 013_2 and the other samples 
is more pronounced and 013_2 is more than 1.5 x the interquartile range below the first quartile, 
thereby classifying the sample as a possible outlier.  
Although MS2Peakwidths was selected as a metric contributing toward 013_2 being identified 
as a possible anomaly, MS2PeakWidths for the entire file did not show any potential outliers, 
nor did the selected samples appear to have very high values for this metric (Fig. 3.8). In 
SwaMe, as the software does not take identification into account, MS2 peaks are calculated for 
each base peak by finding occurences of the same m/z (within the mass tolerance range) within 
the RTTolerance (here set to 2.5 min on either side) of a base peak. Without identification data 
it is therefore very possible that data points could be included that do not form a part of the 
same individual peak.  
In this case, the identification data have therefore granted the Stoychev team additional 
information and illuminated possible problems that did not appear in the automatic curation with 
SwaMe. This highlights the additional value that could be added by analyzing identification data 







Figure 3.8 - MS2Density50(A) and MS2PeakWidths(B) and of the Stoychev dataset. Purple 
lines indicate Q1 and Q3, red lines indicate the Q3+1.5 x IQR and Q1-1.5 x IQR respectively to 
indicate possible outliers. In 013_1, 013_2, 186_1 and 186_2 the average amount of ions 
detected throughout the entire file was low.  Note that 013_2 falls below the bottom red line in B 
and can therefore be considered a possible outlier in terms of its low MS2Density. The samples 
with low TIC and low density also showed low peak widths, which could simply be an indication 
that the data was sparse. 
 
Of the metrics that are not included in the analysis due to low variance, AvgCycleTime and 




provide a metric reporting the number of empty scans in a run. Missing scans together with 
cycle time, peak widths and tailing factor could provide information into excessive background 
noise subtraction, dead volume in the system, ionisation instability, or non-specific binding of the 
analyte/molecule of interest to a surface of non-interest such as a plastic container or pipette 
tip.192  
 
3.3.5 Interrogating experimental design 
A well designed experiment often requires the use of blocking and randomisation.178 Each age-
race-gender matched case/control pair, in the Stoychev dataset, employed a blocking and 
randomisation structure in order to minimise the chance of a batch effect occurring. In a graph 
of the first two principal components of the RT divided quality metrics, the blocks do not 
separate from each other, indicating that during the experiment, the extent of instrumental drift 
was not excessive (Fig. 3.9). In addition, the reruns that were conducted after inspection of the 
peak shapes do not separate from the rest of the dataset. The lack of evidence of instrumental 
drift probably reflects that a little more than two months passed between the original runs and 





Figure 3.9 - PCA of the Stoychev dataset, showing the blocking structure. Therefore there was 
no evidence of a batch effect. 
 
Furthermore, the segment of the RT that the quality metric originates from had a larger impact 
on the first two principal components than the origin of the sample. This is an indication of the 






Figure 3.10 - PCA plot of Stoychev unpublished data. Samples were grouped into blocks to 
avoid case-control batch effects. The RT was divided into ten segments for the purposes of 
inspecting data quality. It is clear that the segment of the RT that the QC metrics refer to had a 
larger impact on the quality metrics for segments 7,8,9 and 10 than the origin of the sample as 
these segments separate from the first six segments in the space of the first two principal 
components.  
In the final biological analysis of the data, the Stoychev laboratory further curated the data 
quality to exclude a number of samples. Here, samples were excluded if their median %CV fell 





Table 3.2 - Samples excluded from biological analysis of Stoychev dataset 
Samples excluded Reason 
003 Data completeness below 10% 
003 rerun  Data completeness below 10% 
006 Injection replicate CV above 20% 
006 rerun Injection replicate CV above 20% 
013 Injection replicate CV above 20% and data completeness below 10% 
013 rerun Data completeness below 10% 
056  Injection replicate CV above 20% 
056 rerun Injection replicate CV above 20% 
141 Data completeness below 10% 
 
 
Fig 3.11 - Boxplots of the %CV of MS2 fragment intensities between injection replicates, 





3.3.6 Abundant ions masking signal 
Upon comparing the MS2TICTotal and the MS2 ion density trends of the Aebersold dataset,182 
we are able to view similarities for the number of ions and the intensity of signal generated (Fig. 
3.12). This similarity becomes important in identifying segments of the RT where a small 
number of ions with high intensity may be masking the signal of other ions and depletion or a 
change in gradient may be considered. In such sections, it is also possible that excessive 
background noise subtraction may have led to a reduction in sensitivity. 
 
 
Figure 3.12 - The average MS2 density plotted against the total MS2 TIC per RT segment of the 
Aebersold dataset. If the majority of the TIC can be explained by a few ions only, the segment is 
at high risk of a few abundant ions masking signals from less abundant ions. Therefore, for the 
first few segments of the RT, fewer ions contributed to the TIC than in the last few segments, 





3.3.7 Analysing Waters MSE data 
The SCIEX TripleTOF and Thermo Fisher Q-Exactive instruments are very specific in the 
number of scans that are collected and the instrument does not deviate from the settings input 
by the analyst. This is not the case in Waters data, where every MS1 scan is not always 
accompanied by a tandem mass spectrum and the tandem mass spectra involves only a single 
window for the entire dynamic range. As a result, we handled the data from this set similar to 
the way we would for the other instruments if only one very wide SWATH was present. In the 
Pereira dataset,12 the swath divided metrics in most cases become a repetition of the 
comprehensive metrics as each cycle contains one window at most and the swath-divided 
metrics therefore only provide one value. For example, MS2Density50 from the comprehensive 
set of metrics provides the average density for all MS2 scans. The metric, swDensityAvg from 
the swath divided metrics returns for each unique isolation window target, the average ion 
density. As all MS2 scans now have the same isolation window target, the two values are equal.  
In this dataset, the quality metrics were influenced more by the time that elapsed after 
incubation than their run order or their case/control status (Fig. 3.13). Where experimental drift 
may have influenced the runs in temporal proximity, the nature of the proteins created by the 
fungus at different growth stages may have had such a large effect in this case that instrumental 






Figure 3.13 - Both cases and controls were run in sequential fashion, so that all the timepoints 
of one sample were completed before another began. The MS2PeakWidths for samples of the 
fungus, Paracoccidioides lutzii, was more similar between different growth stages for the colony 
than they were between runs of similar temporal proximity for the Pereira set184 which was 
collected using Waters MSE.  
3.4 Conclusion 
In this study, experimental and QC DIA datasets from instruments from three different vendors 
were analyzed with the quality control metric generating software, SwaMe. The analysis of 
experimental datasets with PCA illustrates the impact of isolation schemes on quality metrics, 
as well as the importance of block design. In addition, post-hoc analysis of a dataset halted due 




Chapter 4: Assurance - downstream analysis of 
biological mass spectrometry quality metrics 
 
4.1 Introduction 
Command line MS/MS quality tools QuaMeter,99 QuaMeter ID-Free,171 and a new DIA version, 
SwaMe, discussed in chapter three provide valuable quality metrics for discovery proteomics. 
These metrics can support decision making,99,168,171 but this requires the implementation of a 
statistical model in a language such as R or Python. A plethora of free tools available for 
proteomic analysis have allowed bench biochemists to interpret experiments without using 
statistical languages or tools.103,193–195 As a result, one cannot assume statistical programming 
skills in even Ph.D.-trained proteomics researchers. Despite the existence of multiple other MS 
quality tools for bench biochemists that are unrestricted to programming skills,106,108,112 none can 
analyze metrics produced by QuaMeter or SwaMe. In addition, the command line nature of 
QuaMeter can prove daunting to many biologists.  
 
Unfortunately, these hindrances may turn bench biologists away from in-depth quality analysis. 
There is therefore a need to be able to both run command line quality software such as 
QuaMeter and SwaMe through a user interface as well as perform downstream statistical 
analysis similar to that of chapters 2 and 3. The increased accessibility that such a tool provides 
enables a complete pipeline for proteomic analysis and will promote the use of quality control 
software in the field of proteomics. 
The aim of this chapter is to create a tool for the downstream analysis of QuaMeter and SwaMe 




display the distribution within each metric as well as run the command line tool through its user 
interface.  
 
4.2 Materials and methods 
4.2.1 Datasets 
Table 4.1 - Datasets included in the study 
















DDA: 76 manually curated files used for test 
and training, 21 manually curated files used for 
analysis, mzIdentML files are also available for 
all runs 
Tabb142 PXD006843 Orbitrap 
Velos 
DDA: 120 raw files(previously shown in chapter 
2 to have 2-4 quality outliers depending on the 
method) 
 
The datasets used in the analysis include one clinical dataset and one longitudinal dataset.  
For random forest analysis, data from the instrument, Eagle, was extracted from the Smith 
dataset and randomly divided into two sets - the analysis set and a set that would later be 
divided into the test and training set by Assurance. The .mzid files of the test and training set 
created by Amidan and colleagues (2014) were also used to allow classification of bad quality 




quality data has been manually curated by experts in the field.168 This curation was used to 
annotate “good” and “bad” data by uploading a .tsv file of the QuaMeter ID-Free metrics 
(Available at https://github.com/marinaPauw/Assurance/releases). This approach was 
compared to classifying “bad” data on the basis of their identification data from mzidentMLs 
created as a part of the original analysis168 via MSGF+. 166 
Assurance offers two separate methods for a manual classification of the samples into “good” 
and “bad” quality. The first involves uploading identification files and selecting “bad” quality files 
from a graph of the spectral counts. The other involves the uploading of a tsv file of the quality 
metrics and selecting rows from this table as “bad” quality. 
4.2.2 Explanation of Assurance structure 
The main window provides the option of either running QuaMeter, SwaMe or uploading 
previously produced results (Fig 4.1). Arguments for running the tools can be adjusted to reflect 
instrument type, and the terminal output is displayed in a window. If SwaMe or QuaMeter is run, 
output files are automatically loaded upon completion. The quality metrics can then be used to 
detect outliers and/or interrogate each metric separately and/or perform random forest analysis 
for longitudinal data. This last requires the upload of additional data that will be balanced and 
randomly divided into a test and training set for classifier evaluation as well as allocating the 





Figure 4.1 - Flow diagram representing an Assurance run. 
4.2.2.1 Unsupervised outlier detection via PCA 
For the PCA Assurance employs the Scikit-learn197 package. Non-numeric columns and 
columns with less than 1% variance are removed. In the case of columns that are more than 
99% correlated, the tool selects the first column excludes the others. The data is scaled and 
PCA performed. Thereafter, the tool determines the number of significant components using the 
Elbow method and a distance matrix is created. The median of the distances for each run is 
calculated and possible (1.5 x IQR above Q3) and probable outliers (3 x IQR above Q3) of the 
medians are indicated in blue and red respectively.196 For easier reading, in the rest of the 
chapter, possible outliers have been abbreviated to “PossOut” and probable outliers to 
“ProbOut”. The data excluding ProbOuts can be reanalysed to determine if initially discovered 




4.2.2.2 Visualisation of metrics  
Individual metrics are arranged in order of ascending value and plotted as a line graph. In 
addition, for numerical metrics the first(Q1) and third(Q3) quartile as well as Tukey’s designation 
for possible outliers (Q1+1.5 x the interquartile range(IQR) and Q1-1.5 x IQR)196 is represented 
as horizontal lines. 
4.2.2.3 Longitudinal analysis via Random Forest 
The execution of random forest analysis involves the h2o package.198 The package runs the h2o 
jar executable via Java and creates a local server enabling the rapid analysis of large quantities 
of data. Additional data in the form of a training and test set must be uploaded. Classification of 
this set can occur via the uploading of identification files and selecting from a subsequent graph. 
The allowed file formats are .mzid199, .pepXML and MaxQuant tab-delimited summary 
statistics.193 Alternatively, a table of the quality metrics can be used for classification. The 
dataset is randomly divided into training and test data and hyper parameterization used to 
create a model. The model is then trained, tested and used for classifying the analysis data. 
Performance metrics of the test set, metric contribution and the probability of being classified as 
‘bad’ for each sample is displayed. 
4.2.2.3.1 Classifying the training set from quality metrics 
The “Curated Quality” column (Fig. 4.2) in the test and training set data was used to select all 
the samples. The samples for this set had been manually curated by experts in the field based 
on identifications, peak shape and other characteristics into three categories: “Poor”, “ok”, and 
”good”. This column is present in the quality data downloaded as part of the supported 
materials.168  
For the purposes of our work, we will consider both “ok” and “good” as samples with good 




training, there were 33 samples of “ok” and “good” quality and 43 samples of “poor” quality. If a 
researcher has prior knowledge on the quality of data for the test and training set as is expected 
with longitudinal data, a column can be safely added to the QuaMeter .tsv file to discern this 
difference within Assurance and to increase the process repeatability. As long as the column 
heading is not also present in the analysis data, it will not be included in training the model. 
 
Figure 4.2: Screenshot of the selection of the poor quality data from the 
EagleTrainingandTest.tsv available at https://github.com/marinaPauw/Assurance/releases.  
 
4.2.2.3.2 Classifying the training and test set from the number of spectral IDs 
As an alternative strategy, the identification results were uploaded and the 28 samples with the 
lowest spectral counts were annotated as ‘bad’ due to a natural grouping in the dataset (Fig 
4.3). However, in the case of a researcher that does not have any indication of which data 




such as data in the bottom quartile of the identification distribution or data that make up the 
average -1.5x IQR. In the case of the Tabb dataset. After the allocation, the quality files were 
uploaded. The quality files are then used to train and test the model and the identification files 
are excluded from the rest of the analysis. 
 
 
Figure 4.3: Screenshot of the selection of ‘bad’ quality files from the Smith dataset as the 28 
samples with the lowest number of identified spectra. 
Whichever method is chosen,  it is therefore of utmost importance that the test and training set 
be correctly classified. It is advisable to run the test and training set through the outlier detection 
to ascertain that there were no quality outliers in the “good” quality section. 
4.2.3 Report generation 
After running one or more functions, the software can generate a pdf report. Accreditation in the 




quality in the form of reports. Often this entails storing both hard copy and electronic versions for 
audits and for review in the case of a customer complaint or a product quality query. The PDF 
creation function of Assurance is easily printed and stored electronically to fulfill quality 
accreditation requirements. 
4.3 Results and Discussion 
4.3.1 Outlier analysis on the Tabb dataset 
Upon performing PCA on the Tabb dataset (Fig 4.4), two data points that had previously been 
identified as anomalies in chapter 2 are again noted (SW2-1-9, SW2-1-10). However, six 
additional samples are noted as ProbOuts (>= 1.5 x IQR from Q1/Q3) in red and five more are 







Figure 4.4: Screenshot of the outlier analysis results for the Tabb metrics. The ProbOuts are 
marked as red data points and the PossOuts are marked in blue. To the left of the PCA plot, the 
PossOuts and ProbOuts have also been listed.  
 
This discrepancy between the results noted here and those of chapter two (Fig. 2.2) is the 
consequence of a slight difference in methods. During analysis in chapter two, a robust PCA 
was constructed in R. Given that Assurance may be employed on sets containing fewer 
experiments, the software was developed around a conventional PCA computed with sklearn 




had a large effect on the PCA. This is also visible when noting the other PossOuts and 
ProbOuts are the closest to the outlier samples on the first axis, indicating that the weight of the 
two most obvious anomalies had a large impact on the positioning of data points in the first two 
principal components. 
By toggling the loadings checkbox, it becomes apparent which metrics are responsible for the 
sample positioning in the graph (Fig. 4.5).   
 
Figure 4.5: Screenshot of the outlier analysis results for the Tabb metrics with the loadings 
annotated in purple. MS1-TIC-Q3 and MS1-TIC-Change-Q3 notably increase in the direction of 
the two most prominent anomalies and for clarity they have been circled. 
Due to the large distance between the two prominent aberrations and the bulk of the data, it is 
very possible that additional outliers in the dataset may be masked by the effect that the 




After re-analysis without the ProbOuts, two new ProbOuts are noted. The six PossOuts also 
differ from the first analysis. 
 
Figure 4.6: Screenshot of the anomaly analysis results for the Tabb metrics after reanalysis with 
the metric contributions annotated. For this reanalysis, the ProbOuts and PossOuts were not 
noted in the previous analysis and metrics RT-TIC-Q2, RT-MSMS-Q3 and MS2-PrecZ-1 
increase in the direction of the anomalies, with MS1-TIC-Q3 and MS1-TIC-Change-Q3 
decreasing. 
4.3.2 Individual metrics of the Tabb dataset 
The very first metric in the individual metrics section, StartTimeStamp, illustrates the 23-day gap 
in the data noted in chapter 2 (Fig.4.7). This project demonstrates the value of including 






Figure 4.7: Screenshot of the first individual metric, runDate. Samples were run sequentially 
until a marked 23-day gap occurred. Noticeably, the gap occurred directly after the two most 
prominent outliers were analysed. The selected sample - indicated in green, can be changed by 
clicking a data point or via the dropdown menu at the top-right. 
 
When viewing the metrics indicated to contribute to the status of the ProbOuts, such as MS1-
TIC-Q3, it becomes clear that the two most prominent anomalies were indeed a large distance 
from the rest of the sample distribution. In addition, the other samples identified as ProbOuts 
before the reanalysis are visible here as the samples with the next six highest values. This is 
again indicative that the metrics in which the two most prominent aberrations were outliers 
played a very large role on the principal components and may indicate that the additional 
ProbOuts in this dataset may not be true anomalies. When inspecting the distribution of this 
dataset it is clear that sample H-1-2-4 has a value greater than the Q3+1.5x IQR as is indicated 





Figure 4.8: Screenshot of MS1-TIC-Q3 for the Tabb dataset. Note the two most prominent 
ProbOuts are located far above the blue line depicting Q3 + 1.5 x IQR, marked in the graph as 
“Out: 1.32”. The other samples that had been classified as ProbOuts follow as the next highest 
values for this metric. 
 
4.3.3 Random Forest analysis of Smith dataset 
This dataset was manually curated by experts as “good”, “okay” or “poor” based on identification 
results. The test and training set for the random forest analysis was classified in one of two 
ways. In the first case, the quality metrics were combined into a table and a column was added 
with the manual curation results of test and training set. The data curated as “poor” was 
allocated to the “bad” quality group and the data labelled “okay” and “good” during curation were 
designated “good” data. The second strategy involved viewing the identification results and 




4.3.3.1 Comparison of the two classification strategies 
The model resulting from the quality table classification strategy showed an accuracy of 54.84% 
when tested on the testing data and classified 16 of the 21 samples as ‘bad’(Table 4.2). The 
proportion of trees that voted each sample as bad is noted in Fig 4.9. 
Table 4. 2: Comparison of the two methods with the manual three level classification system of 
experts in the original article 3 Manual curation of “ok” and “good” quality were both considered 
to be “good” in our binary classification system, where “poor” was considered to be the same as 
“bad”. Where the model’s predictions agreed with that of the manual curation the cell was 
coloured green(true positive (TP) and true negative (TN)),  else red (false positive (FP) and 














QC_Shew_12_02_Run-14_6Sep12_Eagle_12-06-13 good TP FN 
QC_Shew_12_02_Run-16_6Sep12_Eagle_11-10-18 good TP TP 
QC_Shew_12_02_Run-13_28Aug12_Eagle_12-06-09 ok TP FN 




QC_Shew_12_02_Run-09_28Aug12_Eagle_12-06-09 ok TP FN 
QC_Shew_12_02_Run-12_5Sep12_Eagle_12-06-13 ok TP FN 
QC_Shew_12_02_Run-02_28Aug12_Eagle_12-06-13 ok TP FN 
QC_Shew_12_02_Run-10_22Aug12_Eagle_12-06-13 poor TN TN 
QC_Shew_12_02_Run-06_23Aug12_Eagle_12-06-13 poor FP TN 
QC_Shew_12_02_Run-05_28Aug12_Eagle_12-06-09 poor TN TN 
QC_Shew_12_02_Col-4_Run-12_18Aug12_Eagle_11-10-
18 
poor TN FP 
QC_Shew_12_02_Run-04a_25Sep12_Eagle_11-10-18 poor FP TN 
QC_Shew_12_02_Run-7_22Aug12_Eagle_12-06-09 poor TN TN 
QC_Shew_12_02_Run-05_24Sep12_Eagle_12-06-09 poor FP TN 
QC_Shew_12_02_Col-4_Run-4_18Aug12_Eagle_11-10-18 poor TN TN 
QC_Shew_12_02_Run-10a_25Sep12_Eagle_12-06-13 poor FP TN 
QC_Shew_12_02_Run-9_22Aug12_Eagle_12-06-09 poor TN TN 
QC_Shew_12_02_Run-14_23Aug12_Eagle_12-06-13 poor TN FP 
QC_Shew_12_02_Run-01_30Aug12_Eagle_12-06-09 poor TN TN 
QC_Shew_12_02_Run-15_5Sep12_Eagle_12-06-09 poor FP TN 






Figure 4.9: Screenshot of the proportion of trees that voted each sample in the quality metrics 
file classification round as ‘bad’. The samples classified as bad are marked in red.  
 
The metric contribution indicated RT-TIC-Q1 and MS1-TIC-Q2 as the two main contributing 





Figure 4.10: Screenshot of the metric contribution for the random forest analysis via table of the 
quality metrics. 
On the other hand, the model that was classified from the graph of the identification files 
showed 76.67% accuracy on the test set and 9 samples were identified as ‘bad’ quality. The plot 
representing the proportion of trees that voted each sample as bad is displayed in Fig. 4.11. The 
metric contribution is displayed in Fig 4.12. The metrics contribution order between the two 
techniques is clearly very different, with RT-TIC-Q3, the highest contributing metric when the 
quality table was used, in 31st place when the identification graph is used. RT-MSMS-Q2 which 
was 32nd when the quality metrics were used is first when the graph of identification metrics is 





Figure 4.11 - Screenshot of the proportion of trees that voted each sample as ‘bad’ if a graph of 
the identification data was used.  
 
Figure 4.12: Screenshot of the metric contribution for the random forest analysis via table of the 
quality metrics. 
 
Working from the assumption that the manual curation performed as part of the original study 




21 samples and classification via quality table resulted in 14 correct predictions (Table 4.2). The 
prediction from identification samples resulted in a ‘good’ predictive value of 0.46 and a ‘bad’ 
predictive value of 0.17, whereas the quality metrics based classification resulted in 0.4 and 
0.69 respectively. However, the sensitivity was 0.5 and 0.28 and the specificity was 0.50 and 
0.79 for the identification approach and the quality approach respectively (See Suppl. Table 3 
and 4 for the confusion matrices). The quality based approach was therefore more specific and 
resulted in a more stringent classification of samples as ‘bad’ quality, however the identification 
classification approach resulted in higher correct predictions overall. 
The manual curation made by experts in Amidan et al.,(2014) which consisted of a three level 
classification system, “good”, “ok” and “poor”, was made from “base peak chromatogram, total 
ion current chromatogram, plots of both the top 50 000 and top 500 000 LC−MS detected 
features, and the number of peptides identified”. The identification based strategy showing a 
higher correct prediction in this example, may therefore be related to the curation strategy. 
 
Table 4.3 - Confusion matrix from the analysis made with a table of quality files 
 
 Predicted ‘Good’ Predicted ‘Bad’ Total 
Manually curated ‘ok’ and ‘good’ TP = 2 FN=5 7 
Manually curated ‘poor’ FP =3 TN=11 14 






Table 4.4 - Confusion matrix from the analysis where the training set was classified from a 
graph of identification files 
 
 Predicted ‘Good’ Predicted ‘Bad’ Total 
Manually curated ‘ok’ and ‘good’ TP = 6 FN = 1 7 
Manually curated ‘poor’ FP = 6 TN = 8 14 
Total 12 9  
 
4.4 Conclusion 
Assurance provides a useful analysis tool for running command line quality tools, QuaMeter and 
SwaMe and analyzing data. It is clear that in the outlier detection method, two of the anomalies 
that were most prominent were such a great distance away from the rest of the data that the 
subsequent PCA was influenced by the outliers. This analysis therefore indicates the 
importance of applying insight to statistical results. Random forest analysis where classification 
was done via identification results was more sensitive and showed more correct predictions in 





Chapter 5: Discuss 
5.1 QC and reproducibility in an identification-driven field 
Traditionally the success of a proteome analysis technique, software or experiment is often 
measured by the number of peptide/protein identifications with the ultimate goal of observing as 
much of the proteome as possible.200 It is certainly true that a publication bias toward higher 
identifications may drive the experimental focus away from reproducibility.201 The question 
arises whether our competition for identifying the highest number of peptides/proteins is the best 
approach to enhance the proteomic field. In 2014, a retrospective analysis was conducted on 
two publications in the journal Nature. Both studies claimed to have identified the largest 
number of proteins in the human proteome to date. However, despite neither of the two studies 
including nasal tissue, 108 and 200 olfactory receptors were found in the two studies 
respectively.202 At the time of writing this thesis, these publications had 650 and 551 citations 
respectively, indicating that despite the perception of uncontrolled false identifications, the 
proteomics community still considered these publications valid and important. 
Although a study identifying many peptides can correlate with all the correct quality practices 
and analyses, the pursuit of reproducibility and high identification counts can be 
counterproductive. For example, by performing a more constrained search rather than seeking 
to identify as many different peptides as possible, the reproducibility of the analysis could be 
increased as is demonstrated in the recent unveiling of a new dual-search technique.203  
In addition, due to budget constraints, a researcher may need to decide between replicates or 
fractions of the sample. Where multiple fractions are traditionally employed to lessen the 
complexity at the detector, thereby possibly increasing the number of identifications, replication 
is traditionally employed to increase reproducibility and statistical power. This choice may 




The pursuit of high levels of reproducibility goes further than the quality metrics and 
experimental design discussed in this thesis. A 2016 study found 20-50% of false positive 
peptide identifications in the datasets they analysed to be the result of modified peptides.204 As 
anyone in the field of science may know, irreproducible science is at its best unproductive; at its 
worst, it may be the spark for time-consuming and financially costly unproductive follow-up 
studies. Similarly destructive, an irreproducible study could mask significant and valuable results 
and without the proper study limitations noted, other researchers could be discouraged from 
pursuing valuable hypotheses. An argument can therefore be made that a shift in our scientific 
goals is needed, from a pursuit of achieving the highest number of identifications, to the highest 
degree of reproducibility. 
The topic of reproducibility also brings about a discussion of metrics of reproducibility. Many 
articles utilize the overlap in peptide identifications as reproducibility of identification, without 
including quantitation. The question then arises whether the overlap in identification is sufficient 
as a metric by which to measure reproducibility. In the light of this thesis and the corresponding 
quality studies, one is tempted to ask whether quality metrics may prove a less biased 
assessment of reproducibility.  
5.2 Overall study outcomes 
There is a need for an in-depth QC metrics producing software for DIA. Furthermore, the 
possibility that a bench biochemist can perform all the rest of the analysis without learning a 
statistical language, provides a clear motive for increasing the accessibility of command line 
quality tools and their downstream analysis. The present study involved the creation of SwaMe, 
a metrics producing software for DIA and Assurance, a statistical downstream analysis tool for 
analysing quality metrics. The overall aim of the study was to provide researchers with the 





Much emphasis was placed in this study on identifying sources of variability. This step is 
extremely important both in method development, but also in verifying that there were no batch 
effects present in a study and that the experimental design was sufficient at the conclusion of 
the experiment. If fractionation can be taken as an example, the large contribution that this step 
has to the experimental variability should be considered in light of the evidence that the number 
of identifications of a sample were not always increased as we showed in the DDA analysis in 
chapter two. In addition, studies in DIA have found that libraries generated from fractionated 
DDA samples did not always improve the number of DIA identifications.206 Such analysis could 
just as easily be used in common quality control analysis to find areas of the analysis where 
analysts can improve the reproducibility of their technique. 
Chapter three on the other hand highlighted that for DIA, the isolation window structure plays a 
large role in the quality metrics. The experimental conditions, outside of LCMS analysis, such as 
cell culture were also highlighted as a major contributor to sample variability. Although it may 
have been expected in the peptide identifications, it was interesting to see this trend in the 
quality metrics. Even in chromatography based metrics, this trend was visible indicating that it is 
not simply a case of the number of peptides being comparable between groups. I hypothesize 
that this tendency is rather due to the different peptides being produced during the different 
growth phases.  The similarity between the last two groups also suggest that the organism may 
have been entering a stationary phase or at least that the exponential growth phase was 
starting to plateau. 
With both chapters two and three demonstrating how to inspect a dataset for variability, a 
researcher with access to a statistical language such as R or another statistical tool can 
replicate the analysis in their own dataset. The degree of personalization (dividing the 
experiment into groups) required to conduct this type of analysis is not currently possible with 





The datasets included in this study showed that some of the fundamental experimental design 
strategies such as blocking, randomization and random block design need to be emphasized in 
proteomics. Over the last two decades, there has been an increase in significance of 
experimental design in the proteomics community, perhaps due to a large amount of data being 
produced in the 1990’s that could not be biologically validated.207 It is not uncommon to observe 
a course on experimental design included in proteomics workshops and conferences,208,209 and 
since the first journal article established this principle in 2004,210  journals frequently offer guides 
on the implementation of such strategies. 
A plethora of articles also exist on the subject to increase the visibility. Hu and colleagues 
discussed three cautionary case studies with much the same message as ours in chapter 
two.211 Their cases cluster according to the run date rather than any of the biological trends, 
they reported biological groups that were run a month before the other groups indicating clear 
batch effects. Furthermore, they show a case study where the protocol was changed halfway 
through and due to a lack of Fisher’s design principles this also resulted in a batch effect. Their 
third case study demonstrated instrumental changes resulting in a mass error, which was only 
applicable to a subgroup of their study which was incorrectly interpreted as a biological 
difference rather than as a poor design artifact. The question then arises, given the amount of 
data available to researchers that emphasize design, why did less than a fifth of the datasets in 
chapter two apply experimental design? By comparison, in chapter three, two out of the five 
datasets analyzed with SwaMe, the Stoychev dataset and the Steen dataset, did indeed apply 
randomized block design.  I hypothesize that two factors could be responsible for the low 
percentage of datasets that used blocking/randomization, a trend that is especially prevalent in 
chapter two. Firstly, the date of the experiments plays a large role. Although none of the 
datasets were run prior to the Hu and colleagues article,211 the argument can be made that the 
more recent studies have had more exposure to the principle of experimental design and that 




datasets with randomized and/or blocking design in chapter three as DIA is a more recent 
technique. Some of the chapter two experiments predate the popularization of this technique for 
proteomics.8 
The second possibility that I hypothesize is that researchers may be employing experimental 
design in their bench practices, but as many biologists may send their samples to a core facility, 
it is possible that the design is not communicated to the core facility and that the run order is the 
only part of the experiment that does not follow the design principle. However, as mentioned in 
the study by Hu and colleagues, as well as with some of the studies in chapter two, one 
biological group is sometimes run weeks before the other, indicating the researcher is aware of 
the timeline. One of the metrics that is produced by both QuaMeter and SwaMe (and the first 
metric displayed by Assurance when working from data from these tools) is StartTimeStamp. As 
seen in chapter four, the 23-day gap in the run dates of the Tabb dataset is unmistakable and to 
get to any other metric, the researcher is first confronted with this gap in the timeline. If the 
researcher had sent samples away to be analyzed elsewhere, any ignorance in the 
experimental design is corrected.  
An important consequence of a study such as this might be termed the “QC fail dilemma.” In this 
scenario, a researcher who has already completed an experiment and is, for example, writing 
up a manuscript may attempt a run with a quality control tool such as SwaMe and/or Assurance 
only to find one or more runs registering as anomalies. This researcher is now faced with a 
number of choices, depending on the experimental design of the experiment. If the study had 
ample funding for replicates, the researcher may be lucky enough that the outliers may have 
fallen in replicates of different samples and the number of replicates of said samples could 
simply be reduced. If no replicates are present, but the experimental design has allowed the 
outlier samples to occur in different conditions, assuming that rerunning the samples is not an 
option, this fact could simply be noted. However, in the worst case scenario, where multiple 




very clearly in the manuscript, to avoid deceiving the readers. In this manner, anyone who reads 
the paper and may have conflicting data, or may be planning a similar study of their own, would 
know that a possibility exists that the trends seen in the data could be the result of a batch 
effect. If a researcher of a proteomics experiment is able to rerun samples, it is advised to rerun 
an entire block of samples again. In this manner, the samples within the block can be compared 
to each other and the time that has passed from the first runs to the second group will not result 
in a batch effect. 
It is important to note that this study was focused mainly on proteomics with data-dependent or 
data-independent acquisition. Targeted acquisition has very different quality considerations to 
discovery, similarly, the acquisition strategy impacts the dynamic range, MS2 complexity and 
other factors.212 
It is particularly gratifying from a traditional QC analysis viewpoint to note that SwaMe was able 
to detect the quality anomaly in the Steen dataset prior to the occurrence. A mass spectrometer 
is made up of connected parts, not all of which can be monitored in real time. It is therefore very 
important to be able to narrow down the search to a specific type of problem as manufacturers 
guidelines indicate the problem could be occurring in any of a number of steps.213–215  
If the different outlier detection techniques used throughout this study are compared, we are 
presented with interesting results. The robust PCA, identification analysis and non-robust PCA 
identified the same two samples as anomalies in the Tabb dataset, SW2-1-9 and SW2-1-10. 
However, the additional two samples that were detected in the identification method indicate 
some of the fundamental differences between using an identification method and a quality 
based one. It is still common conduct to use the number of identified peptides as a measure of 
the quality in a discovery experiment,216 or at least combined with quality metrics.168 It is 
therefore worthwhile to note the runs that show a difference in these metrics. In the case of the 
Tabb dataset, three out of the four of the fraction number 10 runs from the SAWC3561 sample 




aberration in quality, with so much data at hand it would appear that perhaps the other three are 
possibly a biological trend. The 10th fraction was the last, so a slight difference in the 
fractionation process which consisted of a manual selection of gel segments could have 
resulted in less peptides in this fraction. This is still true despite the fact that we have 
complimented the analyst on a remarkably reproducible gel segment selection in the experiment 
as a whole. Several additional samples were selected in chapter four where a non-robust PCA 
was used. The influence of anomalies on classical PCA  is well-known in statistics.217 
In addition, Tukey’s criteria for an outlier always assumes a certain degree of symmetry, and 
when anomalies as far from the rest of the data as those in the Tabb dataset occur, the 
skewness that results may highlight a larger group of data points as outliers than expected.218 It 
is therefore advisable to have Tukey’s method for outlier detection paired with a more robust 
PCA. However, the dataset-specific characteristics of a robust PCA made it a little more difficult 
to implement in the generalized setting of Assurance. This indicates that, in Assurance or any 
other setting where a classical PCA is used, a certain degree of manual interpretation is 
necessary in cases of extreme aberrations to ascertain whether all the proposed ProbOuts are 
indeed probable outliers or whether some of the anomalies present have skewed the data. 
All of the above mentioned methods are based on PCA. However, both semi-supervised and 
supervised methods have been investigated for mass spectrometry quality control.114,169 
Supervised learning has the value of allowing expertly curated data as a classifier. In addition, 
where historical data are available, problem runs can be flagged as patterns to seek in future. 
Unlike unsupervised methods which have a garbage in / garbage out problem, supervised 
classification can classify problem areas even if the entire dataset falls under the ‘bad’ quality 
banner. However, there are a number of drawbacks to using supervised methods such as the 
random forest approach in Assurance (reviewed by Su, 2011219). Firstly, it can be hard to 
correctly classify data in a rapidly changing environment and therefore constant re-assessment 




allocated training data and even slight deviances in the training data can throw the entire model 
off. Lastly, it is possible that a different type of problem from the problems added to the training 
set occur in the dataset for classification and is then missed by the supervised classification as 
this problem may closer resemble other data points in the ‘good’ quality group than the ‘bad’ 
quality group as it pertains to changes in different sets of metrics. It is therefore important to 
have the training set encompass as many different problem conditions as possible. 
5.3 Significance of the study 
Applications of discovery proteomics include biomarker discovery research such as the search 
for diagnostic and treatment response biomarkers, drug discovery and identifying disease 
mechanisms. These medical applications are paramount in the fight against both communicable 
and noncommunicable diseases,220–223 and their importance in the present COVID-19 pandemic 
has also been illustrated.224–226 
Dr. Rodriguez also shared HUPO-PSI’s vision for unified metrics, in the pursuit of a more 
reproducible system.227  HUPO-PSI QC team aims to address this issue in the form of the 
controlled vocabulary of mzQC as discussed in chapter one. 2020 has illuminated a situation 
where universal metrics are sorely needed. During the pandemic, researchers found great value 
in preprints/  articles that have not yet been peer-reviewed in fighting an active epi/pandemic. 
With universal quality metrics, the ability to judge for oneself the validity of a study before peer-
review becomes a less daunting task. For example, the QuaMeter metric “StartTimeStamp” 
portrayed in a graph as in chapter 1,2 and 3 can immediately show whether a randomized, 
block or randomized block design was conducted in the runorder. Experimental design is such a 
general scientific term that a genetics researcher for example should be able to spot a batch 
effect whilst reading a proteomics study.228,229 In fact, batch effects in genomics studies 
sometimes even reach popular media and are read by non-scientists.230 Such situations are 




universal metrics such as those produced by QuaMeter or SwaMe will become commonplace 
within the next decade. 
As the world of proteomic quality advances, bioinformatic software must be ready for these 
changes. SwaMe writes and Assurance reads mzQC files, the new format in process from 
HUPO-PSI.227 By implementing this new file type and incorporating SwaMe’s metrics in the 
controlled vocabulary, the software usage is expanded. In addition, an important part of the 
design of both software tools was to make the code available to all and share the knowledge of 
the metric calculations. With such knowledge, the metrics can be improved upon by others in 
the scientific community as the instrument usage grows and changes. The collaboration with the 
University of Manchester in the production of SwaMe has also broadened the scope of SwaMe’s 
implementation and allowed fresh insight and an outlook and interpretation unique from our 
own. Our collaborators have devised a very intricate and informative set of metrics that come 
especially handy in longitudinal analysis. For example, they have thought of using the stability 
awarded by calibrant peptides in the quality setting and have included metrics such as 
iRTOrderedness. Together, SwaMe has become a more powerful, useful tool that will be more 
robust to changes to the technique in the future. 
SwaMe is the first software of its kind for DIA proteomics. The tool allows an in-depth analysis to 
a point that has never been possible before by segmenting the RT and m/z axis in the form of 
different windows and providing metrics for each segment. DIA is marketed as more 
reproducible than DDA proteomics,206,231,232 which leaves the concern that the statement may be 
interpreted by researchers as an excuse to not implement proper QC protocols. It is therefore 
important to improve accessibility of QC in this field so that this factor does not add to possible 
reasons proper QC is avoided. 
This thesis relied heavily on public data repositories. The advent and rising popularity of data 
repositories enables not only the a posteriori quality analysis of data with quality tools,200 the 




also of course brings us closer to the goal of transparency.205 This scale of data repository 
usage was not present a few decades ago and this study demonstrates the importance of public 
repositories. 
5.4 Study limitations 
Although care was taken to include instruments from three different vendors in our DIA analysis, 
regrettably, the new and exciting technology of TIMSTOF and associated ion mobility (in-source 
or in mass spectrometer) were not included in our design of SwaMe. It is very possible that the 
popularity of these techniques might increase in the future, rendering their absence from 
SwaMe a limitation of the software. 
Assurance is a windows-based software, however, this decision was made with the reasoning 
that most command-line/programming shy users would also not utilize Linux.  
SwaMe takes as input the standard HUPO file format, .mzML. There are analysis tools that do 
not require the conversion from raw file to standard format,24 however some analysis tools that 
do not require this format advise the conversion for optimal performance,103 and there are others 
that cannot operate without the conversion.194,195,233  
As mentioned previously, Assurance currently is not equipped to show different grouping 
structure in different colours in a PCA graph. This is due to time constraints, but would be very 
interesting to add at a later stage. 
In addition, SwaMe does not consider identification-based metrics. As there is such a 
discrepancy between different identification software, this avenue could be considered a 






Chapter 6: Conclusion and future works 
6.1 Conclusion 
The aims of this study included creating tools for the analysis of DIA proteomic data QC metric 
generation and the downstream analysis of metrics for both DDA and DIA. In addition, I set out 
to illustrate how quality metrics could be used in a conventional manner to detect outliers as well 
as a novel probing of quality metrics to determine the main sources of variability in the rest of 
the experiment. 
In addition, I highlighted the importance of experimental design and how quality tools can be 
used to ascertain whether the correct experimental design strategy was chosen. In chapter 5, 
the significance of the study and the contribution to the field was discussed along with the study 
limitations. 
This thesis has produced one published article and two publication ready manuscripts. I have 
presented at one national proteomics workshop hosted in South Africa,234 one national 
bioinformatics conference,235 as well as hosting a tutorial for the detection of quality outliers in 
mass spectrometry data at an international meeting of HUPO-PSI in 2019,236 hosted in Cape 
Town. At this meeting the collaboration between University of Manchester and Stellenbosch 
University began after realizing that we had common goals, but orthogonal objectives that could 
work together very well. It was also at the workshop I presented at this meeting that the 
rationale for creating Assurance became clear as a quick survey eluded that the researchers 
attending the workshop had mostly either never used any statistical toolkit/language such as R/ 




6.2 Future works  
I believe that Assurance is a project that has much potential to grow further. Possible features 
that could be added include the ability to differentiate groups in any of the graphs. For some 
metrics, more informative graph styles might help visualize those metrics (for example a stacked 
bar chart for RT-TIC metrics). In addition, a more detailed description of what each metric 
stands for and how it could be interpreted could be added to SwaMe and QuaMeter metrics.  
Unsupervised and supervised outlier detection methods were selected, however there are many 
other methods available that could be incorporated as options, such as isolation forest237 and 
factor analysis.238 One could allow the parameters of the random forest amongst other methods 
to be set by the user. In addition, the method of declaring an outlier can become an option 
between z-score, modified z-score and MADe (see review218).  
There is also room for new metrics to be added to SwaMe.  The decision to exclude 
identification in SwaMe analysis was taken to prevent identification abnormalities masking 
instrument anomalies. However, the gap between the identification-based outlier detection of 
the Stoychev team and the identification-independent outlier detection performed with SwaMe 
highlighted some of the value of including identification results in quality analysis. Including an 
identification mode in SwaMe in future, could therefore be considered. 
The public availability of the code, (SwaMe:https://github.com/PaulBrack/Yamato, Assurance: 
https://github.com/marinaPauw/Assurance) as well as the collaborative nature of the project will 
hopefully enable and increase the probability that the project will be worked on and added to in 
the future. There is particularly room for addition of metrics related to the m/z axis. A metric 
such as resolution could for example be added to make this area stronger. In addition the m/z 
that is most commonly a base peak of a scan could be pointed out in a metric. 
SwaMe could also benefit from an identification-based mode. If this avenue is taken, one might 
even go further to allow the analysis of for example Geyer and colleagues’s panel of plasma 




adapted for other sample types and once other panels have been developed, they too could find 
a place in an identification-based quality software. 
SwaMe also focused on specific implementations of DIA, hence a technique like ion mobility for 
example is not accurately represented in the metrics.  Incorporating ion mobility features would 
greatly broaden the set of MSE data sets on which SwaMe could be usefully deployed. 
Recent studies have also found success in real-time database searching. 239 The idea revolves 
around performing a database search while the instrument is still gathering data, even deciding 
which precursors to fragment on the basis of those identified so far. These advances, 
particularly when added to the speed of spectral library-based search, enable the rapid 
production of identification-based metrics. If such a technology is incorporated into Assurance, it 
could open up an entire world of combining quality tools with identification in one platform. 
Going the real-time route with quality control software will have tremendous value. 
It may also be useful to conduct a meta-analysis of all datasets submitted to a repository such 
as PRIDE in the last year and perform an anonymous analysis of experimental design to obtain 
a global figure of how many studies implemented Fisher’s design principles. 
There is therefore room for growth both in the analysis and in the development of software parts 
of this study. 
6.3 Proteomics QC in SA 
In a broader sense, proteomics in SA has ample room for improvement. Many instruments are 
located hundreds of kilometers from their nearest neighbours, and an active virtual community 
could make the operation and quality control of these instruments much easier. I suggest this 
could be handled by implementing a similar strategy to one adopted in the National Laboratory 
Association (NLA).240 In the field of microbiology, the association sends out samples of which 
the composition/cfu count is known to the association, but not the analysts. Upon sending 




laboratories in the country. This would be similar to analyzing an E.coli digest or other complex 
sample as a QC step, but it not only allows the comparison of the instrument with a previous 
version, but also allows a researcher to compare their instrument and techniques to other 
laboratories in the country. This is important as standards of acceptable levels of variability 
within an instrument QC metrics can differ with the personality of the analyst, however, feelings 
of inadequacy towards fellow institutions may put things into perspective and spark action. 
Notably, due to a relatively low rate of exchange for our currency and the location of our 
country, attending an international conference or vendor training is a tremendous financial 
expense for South Africans.241 A meeting such as the 2018 HUPO-PSI meeting where 
international scientists visit our country allows many South African scientists to converse and 
collaborate with international scientists, creating relationships and starting projects together. My 
project has shown that this type of international meeting can result in fruitful collaborations and 
potential articles, as well as allowing scientists to discuss solutions to possible problems.  
In addition, our country would profit from an annual meeting for mass spectrometry specialists 
and students. The South African Department of Science and Technology initiative, Diplomics,242 
and the African Centre for Gene Technologies, ACGT,243 have been increasingly active in South 
Africa in organizing international workshops such as the Advanced proteomics course in 2018 
and the Skyline and Trans-proteomic Pipeline proteomics courses in 2019. These courses work 
to increase the skill-level within South Africa without the costly expense of sending scientists 
abroad. However, these courses are typically attended by students, whereas a proteomics 
meeting might include both students and laboratory heads and allow presentation of specifically 
proteomics projects. 
The pandemic of 2020 presented many challenges for academic conferences, however, it is my 
hope that the virtual conferences of this year may consider maintaining some of their virtual 
ability in the years to come. A virtual conference aids in breaking down barriers for lower income 




could now attend a virtual conference hosted overseas, where before the laboratory might only 
be able to send one candidate at most in a year. An increase in remote technologies in all 
forms, conferences, technological support etc. will help South African proteomics to grow. 
6.4 Concluding remarks 
In the previous chapter, the study limitations were discussed, but in this project, as with so many 
others, the main hindrance was time. There is so much more that could be added to both 
softwares to grow their feature sets and improve their usability. It is my hope that the tools 
created as well as the information illuminated by this study will not only be used, but also be 
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Metric name Explanation Units 
MS1/
MS2 Formula if necessary How to interpret: 
      
RT Divided 
metrics 
The user has input a number of segments they want the 
data to be divided into, for example 10. The RT between 
the start of the run and the start+RTDuration is then divided 
by that number to obtain the upper boundary of the 
segments. Any scan with an RT lower than or equal to this 
scan is added to its segment. In our example there are 10 
segments.     
      
MS2PeakWidths 
For each peak within scans that are in the RT segment in 
question, the FWHM is calculated with Crawdad. This 
FWHM is then added to one array for the segment and the 
Secon




average of that array is reported. 
TailingFactor 
Similar to peak widths, only this time the peak tailing factor 
is calculated by Crawdad thanks to modifications to the 
CrawDad source code as a submodule of Yamato. 
Secon
ds 2 




W0.05 / (2 x f)  
MS2PeakCapacity 
The size of each segment (Identical across segments) is 











PeakCapacity is calculated as 
per Dolan et al.,2009, PubMed 
10536823) Equation 1; 
The larger the metric, 
theoretically the smaller 
the peak widths in that 
segment and the higher 
the number of peaks 






For each basepeak, both the mz and intensity of every 
instance in which an ion (not necessarily a bpk) within the 
mztolerance of the basepeak is picked up is added to an 
array for mz and an array for intensity and the mean of 
those arrays are determined. The mean mz is divided by 
the mz at which the basepeak was reported as a basepeak. 
This value is squared and multiplied by the intensity mean. 
The intensity of the basepeak when it was reported as a 
basepeak is then divided by this result. Each peak is 
treated separately, despite the fact that the same m/z may 
be involved in a separate peak. m/z 2 
intensity(basepeak)/ 
mean(intensities of all 
occurrences)* (mean(mzs of all 
occurrences)/basepeakMz)^2 
The larger the value, the 
less precise the m/z 
value of the peak. The 
value is weighted so as 
to not penalise low 
intensity peaks. 
MS1PeakPrecision Same as above, just for MS1 m/z 1 Same as above, just for ms1  
DeltaTICAvg 
The TIC of a scan is subtracted from the TIC of the 
previous scan and the absolute value is then added to an 
array for all scans in the segment, of which the average is 
reported here... 
Intensi
ty 2  
A larger value could 
indicate irregularities in 
the ionization process, 
such as sputter. 
DeltaTICIQR And the Interquartile range is reported here. 
Intensi
ty 2  
A larger value could 
indicate a greater 






If there are ms1scans: This measures the difference 
between the ms1 scan of a particular cycle and the 
starttime of the last ms2scan of that cycle. I know that we 
are then missing the time taking for the last scan of the 
cycle, however we do not have end times for scans with all 
instruments. So while we can use the starttime of the next 
cycle for most of the cycles as an end time, the very last 
cycle will not have this value and in a fixed window model, it 
will then look as though this scan is a different size to the 
others, when it is not necessarily. If there are no MS1 
scans, the first ms2 scan of the cycle is used as starting 
point. This value is then added together for all cycles in a 
particular segment and the average is calculated. 
secon
ds 1+2  
A larger value could 
indicate a longer scan 
time which could be due 
to a larger amount of 






For all the MS2 scans in a particular segment, the number 
of values in the number of ions detected (to be precise the 
number of values in the mz binary array) are added up and 
divided by the number of scans in that segment to get the 
average. 
Count
s 2  
A larger value indicates 
a larger number of ions 
detected in this section 
of the RT on average. 
AvgMS1Density 
For all the MS1 scans in a particular segment, the number 
of values in the number of ions detected (to be precise the 
number of values in the mz binary array) are added up and 
divided by the number of scans in that segment to get the 
average. 
Count
s 1  
A larger value indicates 
a larger number of ions 
detected in this section 
of the RT on average. 
MS2TICTotal 
For all the MS2 scans in a particular segment, the TIC 
values supplied by the mzML are added together. 
Intensi
ty 2   
MS1TICTotal 
For all the MS1 scans in a particular segment, the TIC 
values supplied by the mzML are added together. 
Intensi
ty 1   
      
SWATHMetrics 
For these metrics ms2scans are grouped by their 




grouped into the same swath 
      
ScansPerSWATH Number of scans for that same SWATH count 2   
AvgMzRange 
THis is the isolation window lower limit subtracted from the 
upper limit. This is also not technically a metric, but the user 
can use this information to make sense of the data. m/z 2   
SwathProportionOf
TotalTIC 
The TIC value for all the scans that have the same isolation 
window target mz are added together. This value is then 
divided by the total TIC of all the MS2Scans. 
propor
tion 2   
swDensityAvg 
The number of ions detected (more precisely the number of 
values in the mz binary array) for all of the same swaths is 
added to an array and the mean of this array is reported. count 2   
swDensityIQR 
The value of Q3(75%ile) -Q1(25%ile)  of above-mentioned 
array is reported. count 2   
swAvgProportionSi
nglyCharged 
Each time two m/z values in a scan is 1.00 +-0.001 apart 
we are making the assumption that they are M and M+1 
peaks and that they are therefore singly charged. We count 
the number of these ions detected and divide that value by 
propor




the total number of ions in the scan as the proportion that 
are singly charged. We add these values for all the same 
swaths into an array and calculate the average of the array. 
      
Comprehensive metrics 
      
MissingScans 
The number of scans where 
there was not a single ion 
detected. count    
RTDuration 
Difference between the first 
scan starttime and the last 
scan start time minutes    
SwathSizeDifferen
ce 
Difference between the 
largest swath and the 
smallest swath m/z 2   
MS2Count 
Number of MS2 scans in 
the entire run count 2   




the entire run 
SwathsPerCycle 
Number of swaths in the 
same cycle count 2   
TotalMS2IonCount 
Number of ions detected in 
all MS2scans accross the 
run count 2   
TotalMS1IonCount 
Number of ions detected in 
all MS1scans accross the 
run count 1   
MS2Density50 
The median number of ions 
in all MS2 scans count 2   
MS2DensityIQR 
The IQR for the number of 
ions detected in all MS2 
Scans count 2   
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